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ABSTRACT
Higher-order structures in the 5' untranslated region (UTR) of plus-strand
RNA viruses are known in many cases to function as cis-acting elements in RNA
translation, replication, and transcription. The bovine coronavirus (BCoV) 210
nucleotide (nt) 5' UTR is predicted to contain four higher-order structures
identified as stem-loops I to IV. In this study, evidence supporting the structure
and a cis-acting function in BCoV defective interfering (DI) RNA replication of
two of these structures, stem-loops III and IV is presented. Both stem-loops show
phylogenetic conservation among group 2 coronaviruses and appear to have
homologs or analogs in coronavirus groups 1 and 3 and in the SARS coronavirus.
Stem-loop III has in all coronaviruses for which sequence is known a closely
associated short, AUG-initiated intra-5' UTR open reading frame (ORF). Stem
loop III in BCoV DI RNA (i) maps at nt 97 through 116, and has associated with
it beginning at nt 100 an ORF potentially encoding an 8 amino-acid peptide, (ii)
must maintain stem integrity in the positive and in the negative strands for DI
RNA replication, (iii) shows a positive correlation between maintenance of the
short ORF and maximal DI RNA accumulation, (iv) specifically binds in the
positive strand the 50 kDa viral nucleocapsid protein, and an unidentified viral
protein of approximately 22 k.Da, and (v) in the negative strand specifically binds
seven cellular proteins in the range of 76 to 25 kDa. These results indicate that
stem-loop III might function as a cis-acting element for DI RNA replication
through interactions in the positive strand with viral proteins and in the negative
strand with cellular proteins. Stem-loop IV in BCoV DI RNA (i) maps between
nts 186 and 215, (ii) must maintain stem integrity only in the positive strand for
DI RNA replication, and (iii) specifically binds eight cellular proteins in the range
of 75 to 25 kDa. These results indicate that stem-loop IV might function as a cis
acting element for DI RNA replication through interactions with cellular proteins.
It is postulated that stem-loops III and IV function similarly in the virus genome.
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CHAPTER I. LITERATURE REVIEW.
BACKGROUND
What are coronaviruses? All animal viruses can be grouped into those that
have a DNA genome (the DNA viruses), and those that have an RNA genome
(the RNA viruses). There are seven families of animal DNA viruses, and
seventeen families of animal RNA viruses. Coronaviruses are one of the
seventeen families of animal RNA viruses. Each virus family has a distinctive
virion structure, genome structure, and/or strategy of replication. The coronavirus
family of RNA viruses has all three distinctive features; they are enveloped
viruses that have a distinctive 'crown-like' appearance due to their prominent
surface projections or spikes, hence their Latin name 'corona' (reviewed in Lai
and Cavanagh, 1997); they have the largest known plus-strand viral RNA
genome; and they have a unique replication strategy that involves a discontinuous
transcription step in the production of a 3 '-coterminal nested set of subgenomic
mRNAs (Fig. 1.1).
Coronaviruses belong to the order Nidovirales, which includes the virus
families of Arteriviridae and Roniviridae, in addition to the Coronaviridae.
Coronaviruses cause respiratory, gastrointestinal, hepatic, cardiovascular, and
neurological diseases in animals, and the bovine coronavirus (BCo V) causes
diarrhea in calves (Murphy et al., 1999). In humans, coronaviruses have been
associated with respiratory disease (common cold) (Holmes and Lai, 1996;
McIntosh, 1996), and recently with severe acute respiratory syndrome (SARS)
(Drosten et al., 2003; Ksiazek et al., 2003).
Coronavirus subgroups. There are three coronavirus subgroups, groups 1,
2, and 3 (originally called serogroups) (Lai and Cavanagh, 1997). Some group 1
coronaviruses are TGEV (porcine transmissible gastroenteritis virus), HCoV229E (human respiratory coronavirus-229E), and PEDV (porcine epidemic
1
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Fig. 1.1. Schematic depiction of coronavirus replication. Adapted
from Holmes and Lai, Fields Virology, 1996. Virus entry occurs by
endocytosis triggered by the interaction of the spike (S) protein with
the specific receptor on the cell surface. Replication takes place in the
cytoplasm. Initially the 5' most open reading frame (ORF l a and b) is
translated into polyproteins, which are processed to yield the viral
polymerase and other proteins involved in viral RNA synthesis. The
viral polymerase then uses the genomic RNA as a template to
synthesize full-length negative sense RNAs. The negative RNA is
used as a template for genomic RNA synthesis. Transcription to
produce an overlapping nested set of 3' coterminal sgRN As
containing a common leader RNA sequence at the 5' end takes place.
The leader sequence is depicted by a filled box. Each sgRNA positive
strand has a negative strand counterpart (Sethna et al., 1989). The
sgRNA positive strands are translated to produce the N, M, E, S, HE,
and NS proteins. The N protein packages the genomic RN A into
helical nucleocapsids. Assembly occurs by budding into the
endoplasmic reticulum (ER) and Golgi apparatus, virus particles being
transported to the surface of the cell by the secretory pathway. The S,
E, HE, and M proteins are glycoproteins that are processed in the ER
and are then targeted to the Golgi.
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diarrhea virus). Some group 2 coronaviruses are BCoV (bovine enteric
coronavirus), HCoV-OC43 (human respiratory coronavirus-OC43), HECoV-4408
(human enteric coronavirus-4408), HEV (porcine hemagglutinating encephalitis
virus), ECoV (equine coronavirus), MHV-A59 (mouse hepatitis virus-A59),
MHV-2 (mouse hepatitis virus-2), and MHV-JHM (mouse hepatitis virus-JHM).
IBV (avian infectious bronchitis virus) is a group 3 coronavirus. HCoV-SARS
(human severe acute respiratory syndrome coronavirus) has not been placed in a
group as yet.
Coronavirus genome structure. Coronaviruses are plus-strand RNA
viruses that have the largest known viral RNA genomes (Lai and Cavanagh,
1997). The complete genomes of seven species of coronaviruses [IBV -Beaudette
(Boursnell et al., 1987), BCoV-ENT (Chouljenko et al., 2001), MHV-A59
(Leparc-Goffart et al., 1997), HCoV-229E (Herold et al., 1993), TGEV-Purdue
(Almazan et al., 2000; Eleouet et al., 1995; Penzes et al., 2001), PEDV-CV777
(Kocherhans et al., 2001), HCoV-SARS (Marra et al., 2003)] have been
sequenced and reported in GenBank (Fig. 1.2). The complete genome sequences
of additional strains of BCoV (including the BCoV-Mebus strain sequenced in
our laboratory), MHV, and HCoV-SARS have also been reported. The genome
lengths range from 27,317 nucleotides (nts) for HCoV-229E to 31,357 nts for
MHV-A59. The bovine coronavirus�t1ebus strain studied here has a 31,028 nt
genome that is single-stranded, nonsegmented, and polyadenylated at the 3' end
(Fig. 1.2, Fig. 1.3 A). It has a 210 nucleotide (nt) 5' untranslated region (UTR).
Nucleotides 1 through 65 in the 5' UTR are called the leader region. The leader
also forms the 5' ends of all the bovine coronaviral subgenomic mRNAs. The
bovine coronavirus has a 3' UTR that is 288 nts long, exclusive of the poly[A]
tail. In the genome, the genes are arranged in the order 5'-polymerase (from
ORFs la and lb)- spike glycoprotein (S)- small membrane protein (E)
membrane glycoprotein (M) - nucleocapsid protein (N) - 3'. Several additional
open reading frames (ORFs) are interspersed among these genes. These
3

Fig. 1.2. Genomes of the seven sequenced species of coronaviruses. Adapted
from Brian, 2003, with permission. The SARS genome was adapted from Ruan et
al., 2003, and Snijder et al., 2003. Maps are drawn to approximate scale and
species are shown in decreasing order of size within each of the three groups.
Since the SARS coronavirus has not been placed in a group as yet it is shown in a
separate group from the rest of the coronaviruses (group 4 ). The representations
are derived from data in the GenBank. For gene 1 (ORFs la and lb) the predicted
protease cleavage sites are indicated by numbers and domains of known or
predicted function are shaded and identified (PL, papain-like protease; 3CL,
poliovirus 3C-like protease; TM, transmembrane domain; RdRp, RNA-dependent
RNA polymerase; Z, zinc finger (metal-binding) domain; Hel, helicase domain;
C, conserved sequence domain; SUD, SARS coronavirus unique domain). Genes
2-8 ( or 9) are identified by their transcript name ( 1 a, 1 b, etc.) or their abbreviated
name of the protein product (S, spike; E, envelope; M, membrane; N,
nucleocapsid; HP, hydrophobic protein; HE, hemagglutinin-esterase; I, internal).
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Fig. 1 .3. Observations that led to this research. A. Schematic
depiction of the BCoV genome, the BCoV DI RNA, and the cloned
DI RNA (pDrepl). pNrep2 is a clone of mRNA7 containing the
same 3 0-nt reporter sequence as pDrep 1. Also shown are the
Northern assay replication results. VPl denotes virus passage one
on fresh cells, and indicates progeny virus RNA packaging. B.
Schematic depiction of the 421 nucleotide difference between
replicating pDrep 1 and non-replicating pNrep2 (Chang et al. , 1 994).

6

+

-

additional ORFs encode non-structural proteins of unknown functions. For
BCoV, 18 nonstructural and 8 structural proteins have been predicted (Fig. 1.2).
Coronavirus replication. Shown in Fig. 1.1. The first step in viral
infection is the interaction of the spike (S) protein with the specific receptor on
the surface of the host cell. The BCoV receptor is 9-O-acetylneuraminic acid
(Popova et al. , 2002; Schultze et al. , 1993 and 1994). Virus entry into the host
cell occurs by endocytosis that is brought about by the S protein mediated fusion
of the viral envelope with the cellular plasma membrane or endosomal
membranes. Coronavirus replication takes place entirely within the cytoplasm of
infected cells. Initially the 5' most open reading frame ORF la and 1b is
translated into polyproteins 1a and 1ab, that are cleaved during translation to yield
a viral polymerase (part of gene 1b codes for the actual viral polymerase), and a
variety of peptides (fourteen cleavage proteins, in addition to the polymerase are
predicted for BCoV, shown in Fig. 1.2; K. Nixon and D. Brian, unpublished),
most of them having unknown functions (Lee et al. , 199 1; Bost et al. , 2000; Sims

et al. , 2000). The viral polymerase then uses the genomic positive-strand RNA as
a template to synthesize a full-length, minus-strand copy of the genome (the
antigenome). The minus-strand RNA then acts as a template on which the
positive-strand viral RNA genome is synthesized. In BCoV this step is highly
asymmetric, since approximately 100 positive strands are produced for every
negative strand (Hofmann et al. , 1990). In infected cells, viral subgenomic
mRNAs (sg mRNA) that are polyadenylated at the 3 ' end are also synthesized.
Coronaviruses synthesize six to eight sg mRNA species of different sizes,
depending on the coronavirus species and strain (Lai and Cavanagh, 1997). In
BCoV eight species of sg mRNAs are synthesized. The sg mRNAs form an
overlapping 3 '-coterminal nested set with the viral genome. The smallest of the
sg mRNAs (coding for the N protein) contains the 3'-terminal ORF (the N ORF)
of the genome, and the next larger sg mRNA contains one additional ORF and so
on. All sg mRNAs, except for the smallest, are thus structurally polycistronic, but
7

functionally monocistronic (only the 5' most open reading frame of each sg
mRNA gets translated; with some exceptions). A distinguishing feature of
coronaviral and arteriviral sg mRNAs is that their sequence is discontinuous with
respect to the genome since they contain a common leader sequence which is
derived from the 5' end of the genome. In BCoV all the sg mRNAs contain the
65 nt (nts 1 to 65) leader RNA sequence at their 5' end (Hofmann et al. , 1993).
Though a unique mechanism of discontinuous transcription has been proposed to
function in bringing the leader RNA sequence and the sg mRNA body together
(Cavanagh, 1997; de Vries et al. , 1997; Lai and Cavanagh, 1997; Snijder et al. ,
1998; van der Most et al. , 1995), this process has not been fully understood. Each
sg mRNA is translated to yield only the protein encoded by the 5' most open
reading frame of the sg mRNA (with exceptions). These proteins include
structural proteins N, M, E, S, and HE (hemagglutinin-esterase ), and several non
structural (NS) proteins. The HE protein is not synthesized by all coronaviruses,
but BCoV synthesizes this protein. The BCoV also synthesizes an I (internal)
structural protein whose ORF lies entirely within the N ORF (Senanayake et al. ,
1992). The N protein packages the newly synthesized viral genomic RNA into
helical nucleocapsids. The S, E, HE, and M proteins are glycoproteins that are
processed in the endoplasmic reticulum and then targeted to the Golgi apparatus.
Assembly of the virion occurs by budding into the endoplasmic reticulum and
Golgi apparatus, virus particles being transported to the surface of the cell by the
secretory pathway.
Coronavirus defective-interfering (DI) RNA. DI virus particles are
formed in both RNA and DNA viruses. These are usually found naturally in viral
stocks that accumulate Dis, which are virus particles that contain genomes that
have large deletions, usually of essential functions, but that nevertheless retain
critical replication elements and packaging signals allowing for amplification and
packaging in co-infections with complementing wild type helper virus (Condit,
2001). Dis usually display a replication advantage relative to wild type virus and
8

actively inhibit replication of the wild type virus, presumably by competing for
limited essential replication factors, hence their name (Condit, 2001 ). Since DI
RNAs are amplified efficiently by viral polymerases supplied in trans, and are
shorter than the wild type viral RNA genome making them easier to manipulate
and study, they are extremely useful as model RNA templates for the
identification of viral cis-acting replication signals (Ray et al. , 2003), even when a
full-length infectious cDNA clone of the viral RNA genome has been generated.
To date, a full- length, infectious cDNA clone of the BCoV RNA genome has not
been generated. Full- length, infectious cDNA clones of four other coronaviruses,
TGEV (porcine transmissible gastroenteritis coronavirus) (Almazan et al. , 2000;
Yount et al. , 2000), HCoV-229E (human coronavirus strain 229E) (Thiel et al. ,
200 1 ), IBV (avian infectious bronchitis virus) (Casais et al. , 200 1 ) and MHV -A59
(mouse hepatitis virus strain A59) (Yount et al. , 2002) have been generated.
For BCoV, a cloned, naturally occurring 2. 1 3 kilobase DI RNA (Chang
and Brian, 1 996; Chang et al. , 1 994; Chang et al. , 1 996) (Fig. 1 .3 A) is being used
for the identification and characterization of cis-acting elements for replication.
This DI RNA is a fusion of the 5 ' and 3 ' termini of the genomic RNA (the 5 ' 
terminal 496 nts and the 3 '-terminal 1 63 7 nts exclusive of the poly[A] tail, and a
poly[A] tail of 68 nts). The DI RNA thus has a 5 ' UTR and a 3' UTR that are
identical to those of the BCoV genome. It also has all of the nucleocapsid (N)
gene fused in-frame to part of gene 1 a, resulting in a single, fused open reading
frame. The DI RNA does not have gene l b that codes for the actual viral
polymerase. This DI RNA undergoes replication in the presence of the BCoV
helper virus that supplies the viral polymerase and probably other viral proteins
required for replication. Experimentally, DI RNA replication in helper virus
infected cells is monitored by Northern assays. For this, a strand-specific probe
for a 30 nucleotide reporter sequence within the N gene is used. The cloned DI
RNA construct that has the 30 nt reporter sequence is called pDrep 1 .
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Cis-acting elements for coronavirus replication. With the use of this and
other group 2 coronavirus DI RNA genomes, five cis-acting elements for
replication have so far been reported. Four of these show phylogenetic
conservation and map within the 3' UTR. They are the 3' -terminal poly[A] tail
(Spagnolo et al. , 2000), a long-range stem interaction between nts 65 through 71
and 124 through 13 0 from the base of the poly[A] tail in BCoV (nts 68 through 74
and 136 through 142 in MHV-JHM) (Liu et al. , 2001), a pseudoknotted RNA
secondary structure consisting of nts 173 through 226 from the base of the
poly[A] tail in BCoV (nts 185 through 238 in MHV-A59) (Williams et al. , 1999),
and a bulged stem-loop RNA secondary structure consisting of nts 222 through
289 from the base of the poly[A] tail in BCoV (nts 234 through 3 01 in MHV
A59) (Hsue et al. , 2000; Hsue et al. , 1997). One cis-acting element for DI RNA
replication has so far been reported in the 5' UTR and is the 65 nt leader region
(nts 1 through 65), comprising all of an identified stem-loop I and part of an
identified stem-loop II (Chang et al. , 1994). Cis-acting replication elements in the
5' and 3' UTRs in the coronavirus RNA genome and their counterparts in the
antigenome are proposed to function in genome replication, possibly as sites for
the binding of the viral polymerase (RNA-dependent RNA polymerase or RdRp)
and associated proteins in the formation of the replication complex.
In the research described here, two cis-acting elements for replication of
BCoV DI RNA, in the 5 ' UTR have been identified. These are stem-loops III (nts
97 through 116; Chapter II), and IV (nts 186 through 215; Chapter IV). An
element that probably functions as a replication enhancer has also been identified.
This is the stem-loop III-associated intra-5' untranslated region open reading
frame (intra-5' UTR ORF) (Chapter II).
Proteins found to bind to replication-important cis - acting regions in
coronavirus RNA. Protein binding studies have demonstrated the binding of
twenty three cellular proteins to the 5' and 3' untranslated regions of BCoV and
MHV, another group 2 coronavirus. Of these, four have been identified and are
10

the hnRNP A 1 (heterogeneous nuclear ribonucleoprotein A 1 ), PTB
(polypyrimidine tract binding protein), Poly[ A] binding protein (PABP), and
mitochondrial aconitase (Table 1 . 1 ). Only one viral protein, the N protein has
been shown to bind to the 5 ' UTR (nts 56 through 72), and the ORF l b packaging
signal in MHV, the 3' UTR in IBV, and the 3 ' end of the N ORF (nts 1 44 1
through 1 875) in BCoV DI RNA pDrep (Table 1 . 1 ).
In the research described here, stem-loop III (nts 97 through 1 1 6) has been
proposed to function in replication through its interactions with viral proteins (N
and an unidentified 22 kDa protein) in the positive strand, and cellular proteins
(seven proteins between 25 kDa to 76 kDa) in the negative strand (Chapter 111).
Stem-loop IV (nts 1 86 through 2 1 5) has been proposed to function in replication
through its interactions with eight cellular proteins (between 25 kDa to 75 kDa) in
the positive strand (Chapter IV).

OBSERVATIONS THAT LED TO THIS RESEARCH
Previous studies using TGEV (transmissible gastroenteritis coronavirus)
(Sethna et al. , 1 989) and BCoV (Hofmann et al. , 1 990) had led to the hypothesis
that coronavirus mRNAs undergo amplification by a replication mechanism. In
the study done by Sethna et al. , using Northern blot assays, genomic and
subgenomic length negative strands were found in cells that were infected with
TGEV. While the genomic length negative strand was the minus-strand full
length copy of the genome that is synthesized during replication of the genome,
the subgenomic length negative strands were proposed to be intermediates in the
replication of sg mRNA (Sethna et al. , 1 989). Subgenomic mRNA length
negative strands were later found in cells that were infected with BCoV (Hofmann
et al. , 1 990). This led to the hypothesis that all coronavirus mRNAs might be
undergoing amplification by a replication mechanism. When testing this
hypothesis in BCoV, however, it was found that an mRNA, construct pNrep2 (a
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Table 1.1. Proteins found to bind to replication-important cis-acting regions in
.
.
.
coronav1ruses. Adapted flrom Bnan, 2001, with perm1ss1on.
Protein identity
Binding region
hnRNP Al (35-38 kDa) 3' end of leader (-)\ intergenic sequence nts 70-76(-),
in MHV (Li et al. , 1997)
5' end of leader (+)0 in MHV; complementary strand
Polypyrimidine tractof the genome 3' UTR, nt 53-149 (strong) and nt 270binding protein (PTB)
(55 kDa)
307 (weak) (Huang et al. , 1999; Li et al. , 1999)
Poly[A] binding protein 3' poly[A] tail in MHV and BCoV (Spagnolo et al. ,
(73 kDa)
2000)
Mitochondrial aconitase nt 1-42 from the 3' end of MHV (Nanda et al. , 2001)
(90 kDa)
Proteins of 99, 95, 403' UTR of MHV and BCoV (Spagnolo et al. , 2000)
50, and 30 kDa
Proteins of 120, 55, 40,
nt 129-166 from the 3' end of MHV (Yu et al. , 1995)
and 25 kDa
Proteins of 142, 120,
nt 85-487 from the 3' end of MHV (Yu et al. , 1995)
100, 55, and 33 kDa
Proteins of 120, 103, 81, nt 1-42 from the 3' end of MHV (Yu et al. , 1995)
70, and 55 kDa
Viral nucleocapsid (N)
3' end of leader (+) (Nelson et al. , 2000), and ORF 1b
protein
(Nelson et al. , 2000) in MHV, 3' end of N ORF in
BCoV (Cologna et al. , 2000), 3' UTR in IBV (Zhou et
al. , 1996)
a. Negative strand (-).
b. Positive strand (+).
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reporter-containing mRNA7 that codes for the bovine coronavirus N protein)
when transfected into helper-virus infected cells, does not replicate (Chang et al.,
1 994) (Fig. 1 .3 A). The difference between pDrepl (the DI RNA that replicates)
and pNrep2 (the mRNA that does not replicate) is an additional 421 nucleotides in
pDrepl (Fig. 1 .3 B). This region includes nucleotides 74 through 2 1 0 of the 5'
untranslated region and also part (289 nts) of the ORF l a gene. Thus, it was
thought that these 421 nucleotides might contain cis-acting elements for bovine
coronavirus DI RNA replication. Also, since previous studies had indicated that
ORF l a is translated by ribosomal scanning from the 5' end of the genome
(Senanayake et al. , 1 999), it was proposed that putative cis-acting elements for DI
RNA replication identified within this 42 1 nt region do not function as internal
ribosomal entry site elements directing an internal entry of ribosomes for the
translation of ORF 1 a.
In the research described here two cis-acting replication elements (stem
loops III and IV), and one replication enhancer element (stem III associated ORF)
that map within these 421 nts are characterized.
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CHAPTER II. STEM-LOOP III JN THE 5' UNTRANSLATED
REGION IS A C/S-ACTING ELEMENT IN BOVINE
CORONAVIRUS DI RNA REPLICATION.
INTRODUCTION
The 5' and 3 ' untranslated regions (UTR) in the coronavirus RNA
genome, and their counterparts in the antigenome, are presumed to carry primary
and higher-order structural elements important for genome replication, possibly as
sites for the binding of viral RdRp and associated proteins in formation of the
replication complex. For BCoV, one molecule being used for the identification of
UTR-mapping cis-acting RNA replication elements is a cloned, naturally
occurring 2.13 kilobase (kb) DI RNA that undergoes replication in the presence of
BCoV helper virus (Chang and Brian, 1996; Chang et al. , 1994; Chang et al. ,
1996). The BCoV DI RNA is composed of the fused termini of the virus genome
(the 5'-terminal 496 nts and the 3 '-terminal 1637 nts exclusive of the poly[A] tail
[fused at the third nt upstream of the N start codon], and a poly[A] tail of 68 nts).
To facilitate quantitation of replication by Northern assays, a 30-nt in-frame
reporter sequence has been inserted at a unique Bgl II site at position 1093 to
form construct pDrep l (Chapter I, Fig. 1 .3 A) (Chang et al. , 1 994). To date, with
the use of this and DI RNA molecules from the mouse hepatitis �oronavirus
(MHV), another group 2 coronavirus, five putative UTR-mapping, cis-acting
replication elements have been experimentally identified. Four of these show
phylogenetic conservation and map within the 3 ' UTR. They include the 3 ' terminal poly[ A] tail (Spagnolo et al. , 2000), a long-range stem interaction
between nts 65 through 71 and 124 through 130 from the base of the poly[A] tail
in BCoV (nts 68 through 74 and 136 through 142 in MHV-JHM) (Liu et al. ,
2001), a hairpin-type pseudoknot consisting of nts 173 through 226 in BCoV (nts
185 through 238 in MHV-A59) (Williams et al. , 1999), and a 5' -proximal
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extended bulged stem-loop consisting of nts 222 through 289 in BCoV (nts 234
through 301 in MHV-A59) mapping immediately downstream of the N gene stop
codon and overlapping the pseudoknot by five nucleotides (nts) (Hsue et al. ,
2000; Hsue et al. , 1997). The importance of the 5' -proximal intra-3' UTR bulged
stem-loop in RNA replication has been confirmed in the context of the intact
MHV genome (Hsue et al. , 2000). Within BCoV DI RNA, the 65-nt leader,
comprising all of an identified stem-loop I and part of an identified stem-loop II,
has been shown to function in DI RNA replication (Chang et al. , 1994). The
identity of 5' and 3' UTR-mapping cis-acting elements is consistent with results
of deletion analyses showing dependence of DI RNA replication on coronavirus
terminal sequences (Chang et al. , 1994; Dalton et al. , 2001; Izeta et al. , 1999;
Kim et al. , 1993; Lin et al. , 1994).
Here, we extend our earlier observations on a potential 5' UTR-mapping
stem-loop III (Chang et al. , 1996) and examine its function in DI RNA
replication. We describe its phylogenetic conservation among group 2
coronaviruses, compare its properties with a potential homolog in coronavirus
groups 1 and 3, test its existence in BCoV RNA by further enzyme structure
probing, document by mutation analyses the requirement of the stem for
replication, and identify a potentially important role for the associated intra-5'
UTR ORF in the replication of BCoV DI RNA.

MATERIALS AND METHODS
Virus and Cells. A DI RNA-free stock of the Mebus strain of BCoV at 4.5
X 10 8 PFU/ml was prepared and used as a helper virus as previously described
(Chang and Brian, 1996; Chang et al. , 1994; Chang et al. , 1996; Williams et al. ,
1999). The human rectal tumor cell line HRT-18 (Tompkins et al. , 1974) was
used as previously described (Chang and Brian, 1996; Chang et al. , 1994; Chang
et al. , 1996; Hofmann et al. , 1991; Hofmann, Chang et al. , 1993; Hofmann et al. ,
1993; Hofmann et al. , 1990; Ozdarendeli et al. , 2001; Williams et al. , 1999).
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Plasmid constructs. Construction of pGEM3Zf(-) (Promega)-based pDrep
1 has been previously described (Chang et al. , 1 994). To construct the plasmid
derivatives of pDrep 1 , overlap PCR mutagenesis (Horton et al. , 1 990) was done
using oligonucleotides listed in Table 2. 1 . The strategy used for constructing each
of the derivatives was the same as that for pSLIII-mutlR except for the
differences noted. For making pSLIII-mutlR, Nde l(+), SL3R(-), and pDrep l
DNA were used in the first PCR, Hpal (+), GEM3Zf(-)Nde l (-), and pDrep l DNA
were used in the second reaction, and GEM3 Zf(-)Nde 1 (-) and Nde 1 (+) and the
products of the first two reactions were used in the third reaction to make a 1 1 83nt product that was trimmed to 693 nts with restriction endonucleases NgoM IV
and Avr II and cloned into NgoM IV/Avr II-linearized pDrep 1. For making
pSLIII-mut l L, SL3L(-) replaced SL3R(-) in the first reaction. For making
pSLIII-mutl L/R, SL3L(-) replaced SL3R(-) and pSLIII-mutlR DNA replaced
pDrep l DNA in the first reaction and pSLIII-mutlR DNA replaced pDrep l DNA
in the second reaction. For making pSLIII-mut2L, SRST3L(-) replaced SL3R(-)
in the first reaction and SRST3L(+) replaced Hpal (+) in the second reaction. For
making pSLIII-mut2R, SRST3R(-) replaced SL3R(-) in the first reaction and
SRST3R(+) replaced Hpal(+) in the second reaction. For making pSLIII
mut2L/R, SRST3double(-) replaced SL3R(-) and pSLIII-2R DNA replaced
pDrep l DNA in the first reaction, and SRST3double(+) replaced Hpal (+) and
pSLIII-mut2R DNA replaced pDrep l DNA in the second reaction. For making
pSLIII-mutG 109 ➔ A, SRG 109T(-) replaced SL3R(-) in the first reaction and
SRG1 09T(+) replaced Hpal (+) in the second reaction. For making pSLIII

mutGl l O ➔ A, SRGl l OT(-) replaced SL3R (-) in the first reaction and

SRGl l OT(+) replaced Hpal (+) in the second reaction. For making pSLIII-mut5,
SRAU99(-) replaced SL3R(-) in the first reaction, and SRAU99( +) replaced
Hpal (+) in the second reaction. For making pSLIII-mut6, SR8 1(-) replaced
SL3R(-) in the first reaction, and SR8 1 (+) replaced Hpal (+) in the second
reaction. For making pSLIII-mut3L, SRTlOl C(-) replaced SL3R(-) in the first
reaction, and SRT101 C(+) replaced Hpal (+) in the second reaction. For making
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Table 2.1. or
Oligonucleotide1
GEM3Zf(-)
Ndel(-)
Hpal(+)
Ndel(+)
SL3L(-)
SL3R(-)
SR81(-)
SR81(+)
SRAU99(-)
SRAU99(+)
SRDM(+)
SRG109T(-)
SRG109T(+)
SRGl lOT(-)
SRGll0T(+)
SRleader(-)
SRST3double(-)
SRST3double(+)
SRST3L(-)
SRST3L(+)
SRST3R(-)
SRST3R(+)
SRT101C(-)

d in chaoter II
leotid
Polarity Sequence (5'->3') °
+

GAGAGTGCACCATATGCGGTGT

Binding
region in
pDrepl
2498-25 1 9c

+
+
+
+
+
+
+
+
+
+
+

GGCTGAAAGCTGTTAACAGCAGAAATG
CCTCCAAATCATATGGACGTGTATTC
CCACTCCCTGTATTgmgGCTTGTGGGC
GCTTGTGGGCtatcATTTTTCATAGTGG
CATCCACTCCCTGTATagaATGCTTGTGGGaGTAGATTTTTCATAGTGG
CCACTATGAAAAATCTACtCCCACAAGCATtctATACATTTAGTGGATG
CATCCACTCCCTGTATTCaATGCTTGTGGGCGTtGATTTTTCATAGTGG
CCACTATGAAAAATCaACGCCCACAAGCATtGAATACAGGGAGTGGATG
GTTGATCTTCGACATTGTGACC
CTATGCTTGTGtGCGTAGATTTTTCATAG
CTATGAAAAATCTACGCaCACAAGCATAG
CTATGCTTGTGGtCGTAGATTTTTCATAG
CTATGAAAAATCTACGaCCACAAGCATAG
GATTGTGAGCGATTTGCGTGCGTGC
CACTCCCTGTATagaATGggTGTGtcCGTtct
agaACGgaCACAccCATtctATACAGGGAGTG
CACTCCCTGTATagaATGggTGTGGGCGTAGA
TCTACGCCCACAccCATtctATACAGGGAGTG
GTATTCTATGCTTGTGtcCGTtctTTTTTCATAGTGG
CCACTATGAAAAAagaACGgaCACAAGCATAGAATAC
CCACTCCCTGTATTCTAcGCTTGTGGGCG

140-166
456-481
84-111
102-129
81-129
81-129
81-129
81-129
204-225
98-126
98-126
98-126
98-126
1-25
85-116
85-116
85-116
85-116
93-129
93-129
84-112

Table 2.1. Continued.
Oligonucleotide8 Polarity Sequence (5'->3')b

Binding region in
pDrep l
84-112
SRT101C(+)
CGCCCACAAGCgTAGAATACAGGGAGTGG
SRUTRSTOP(-)
84-128
+
CCACTCCCTGT ATTCTtaGCTTGTGGGCtaAGATTTTTCATAGTG
SRUTRSTOP(+)
CACTATGAAAAATCTtaGCCCACAAGCtaAGAATACAGGGAGTGG 84-128
1098-1123
TGEV8(+)
CATGGCACCATCCTTGGCAACCCAGA
1105-1123
TGEV8b(+)
CATGGCACCATCCTTGGCA
a. The positive and negative symbols in the oligonucleotide names indicate the polarity of the nucleic acid to which the
oligonucleotide anneals.
b. Lowercase bases represent mutated sites.
c. Indicates nucleotide positions in the pGEM3Zf(-) vector.
......

00

pSLIIl-mut4L/R, SRUTRSTOP(-) replaced SL3R(-) in the first reaction, and
SRUTRSTOP(+) replaced Hpa l (+) in the second reaction.
Enzyme structure probing of RNA. Enzyme structure probing of RNA
was carried out as previously described (Ozdarendeli et al. , 2001). Briefly, for in
vitro synthesis of RNA, 10 ug of Xba I-linearized mung bean nuclease-blunt
ended pDrep I DNA in a 200 ul reaction volume was transcribed at 37 ° C for I h
using 80 U of T7 RNA polymerase (Promega) to yield approximately 40 ug of a
595-nt long vector-free transcript. RNA was treated with 10 U of RNase-free
DNase (Promega) at 37° C for 30 min, extracted with phenol/chloroform and
chloroform, chromatographed through a Biospin 6 column (Bio-Rad),
spectrophotometrically quantitated and stored in water at -20° C. For RNase
treatments, 40 ug of RNA was heat denatured at 65 °C for 3 min, renatured by
slow cooling (0.5 h) to 35 °C in a 400 ul reaction volume containing 30 mM Tris
HCl (pH 7.5)-20 mM MgCh-300 mM KCl, and aliquots containing 2 ug of
sample RNA and 5 ug of yeast tRNA were incubated in 100 ul of the same buffer
and 0.05, 0.5, 1, 2, or 4 U of RNase CV I (Pharmacia), 0.05, 0.5, 1, 5, or 10 U of
RNase T l (GIBCO), 0.05, 1, 2, 3, or 4 U of RNase T2 (GIBCO). RNase
digestion was carried out at 25 ° C for 15 min and terminated by the addition of
150 ul of 0.5 M sodium acetate after which the RNA was extracted with
phenol/chloroform, chloroform, and ethanol precipitated. Digested RNA
preparations were used in primer extension reactions with 5 ' -end-labeled plus
strand-binding oligonucleotide SRDM(+) (Fig. 2. 1 ). Undigested RNA was used
with the same primer in dideoxynucleotidyl sequencing reactions to generate a
sequence marker. Products were analyzed on a DNA sequencing gel of 6%
polyacrylamide.
Northern assay for DI RNA replication. The Northern assay was
performed essentially as previously described (Chang and Brian, 1996; Chang et
al. , 1994; Chang et al. , 1996; Hofmann et al. , 1990; Williams et al. , 1999).
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Fig. 2. 1 . Phylogenetic and enzyme structure probing evidence for stem-loop III.
A. Predicted secondary structures within the first 1 26 nts of the 2 1 0-nt 5' UTR of
the BCoV genome and the site from which 5' end-labeled primer was extended
for stem-loop III structure determination. The 65-nt BCoV leader sequence is
shaded and the leader-associated UCUAAAC intergenic sequence (nts 64-70)
found within loop II is identified in bold. The start and stop codons for the intra5' UTR ORF and the start codon for ORF l a are boxed. Previously described
stem-loops I and II are identified. Stem-loop III is shown along with the variant
bases found among the eight sequenced members of group 2 coronaviruses.
Bases named with no superscript are found in all MHV strains (A59, 2, JHM);
superscript identity: 2, MHV-2; a, MHV-A59; j, MHV-JHM; he, human enteric
CoV-4408; e, equine coronavirus. Stem-loop III is identical in BCoV, HEV, and
HCoV-OC43. B. Enzyme probing data for stem-loop III. Depicted is a DNA
sequencing gel showing separation of primer extension products. RNase
digestion conditions for the single strand-digesting RNase T2 and double strand
digesting RNase CV l are described in the text. Lanes 5-8 show the products of
an RNA sequencing reaction done on undigested RNA to identify the base
positions. C. Summary of enzyme probing data shown in part B.

20

A

II

B

116

C

+

◄ ss, strong hit, T2
<l ss, weak hit, T2
ds, strong hit, CV 1

¢ ds, weak hit, CV 1

'

� G U ....
G
U

Y'.♦

U- G

I 1
[;•;··
·'.;;
j,·,·••·..•l
·•·, •
·Uit
. •.·

1 03 -

G - C.
¢

·I �
left

arm

p
, oo

<%I nght

.. ,.,
1

1 2

6

7 8 9 10 1 1 1 2 13

21

14

♦U-G.
A
t> ♦ -U.
♦U-A.
♦C - G. <l

t>

·I 1�� I ·
�tilt

' 1 09

♦C -G.

85
I

93
I

1 26
I

C AC UCCCUGU A U U-A U U U U U CAUAG

• •

AAA

&&&&AA

1 16

Briefly, cells at 80% confluency (~1Xl06 cells per dish) in 35 mm diameter
dishes were infected with BCoV at a multiplicity of 10 PFU per cell and
transfected with 500 ng of DI RNA transcript in Lipofectin (Invitrogen) at 1 hpi.
For passage of progeny virus, supernatant fluids were harvested at 48 hpi and 500
ul were used to infect freshly confluent cells in a 35-mm dish. RNA was
harvested at the designated times and at 48 h after virus passages (VP) 1 and 2.
Total RNA extracted by the NP-40-proteinase K method (yielding approximately
10 ug per dish) was stored as an ethanol precipitate and precisely one fourth of the
preparation was used per lane for formaldehyde-agarose gel electrophoresis.
Approximately 1 ng of transcript was loaded per lane as a size marker. Northern
blots were probed with reporter-specific oligonucleotide TGEV 8(+) 5'-end
labeled with 32P to specific activities of 1.5 X 105 to 3.5 X 105 cpm/pmol
(Cerenkov counts). Blots were read with a Packard Instant Imager
Autoradiography System for quantitation and exposed to Kodak XAR-5 film for 6
h to 5 days at -80°C for imaging. Images were recorded by digital scanning of the
film. In every experiment in which the replication of mutants of pDrep 1 RNA
were examined, wt pDrep1 RNA was examined in parallel.
Sequence analysis of the stem-loop III region in progeny DI RNAs. For
direct sequencing of asymmetrically-amplified cDNA, the procedure as described
by Hofmann et al (Hofmann et al. , 1993) for analysis of plus-strand RNA was
used. For this, oligonucleotides TGEV8b(+) and SRleader(-) were used for R T
PCR with RNA extracted at 48 hpi from cells infected with the first passage virus
(VP l), and in some cases second passage virus (VP2), and 5'end-radiolabeled
oligonucleotide SRDM(+), Hpal(+), or SRleader(-) was used for sequencing.
When mixed sequences were revealed by this method, R T-PCR fragments were
cloned with the TOPO XL PCR cloning kit (Invitrogen) and sequenced.
Synthetic oligonucleotides and accession numbers. Oligonucleotides used
in this study are described in Table 2.1 and GenBank accession numbers for the
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sequences studied are M62375, M1 6620, and M306 1 2 for BCoV-Mebus,
AF523843 for HCoV-OC43 , AF523844 for HECoV-4408, AF523 845 for HEV67N, AF523846 for ECoV-NC99, NC00 1 846 for MHV-2, M27 198 for MHV
A59, M55 148 for MHV-JHM, 234093 for TGEV-Purdue 1 1 6, 6972 1 for HCoV229E, and M42 for IBV-Beaudette.

RESULTS
A predicted stem-loop III with an associated short ORF in the BCoV 5 '
UTR shows phylogenetic conservation among group 2 coronaviruses. Earlier
studies (Bouma, 1 997) using the Tinoco algorithm (Tinoco et al. , 1 973) had
predicted a potential stem-loop III with a helix of seven base pairs and a loop of
six nts mapping at nts 97 through 1 1 6 in the 2 10-nt 5' UTR of BCoV although
enzyme structure probing had indicated the stem was probably eight base pairs
and the loop 4 nts in length (Chang et al. , 1 996). An AUG start codon for an
intra-5' UTR ORF of24 nts was found within the stem beginning at base 1 00. In
the same study, stem-loops I and II were identified as components of a required
5 '-terminal cis-acting element for BCoV DI RNA replication. Structure
predictions, however, have failed to show a consistent pattern for stem-loops I and
II among the group 2 coronaviruses (Chang et al. , 1 996; and data not shown)
suggesting that perhaps a specific sequence rather than higher-order structures in
the 5 '-terminal leader region is important for this cis-acting function.
To further evaluate the higher-order nature of stem-loop III in BCo V, in
the present study, the genomic 5' -terminal sequences were analyzed by the mfold
program of Zuker (http://bioinfo.math.rpi.edu/,--zukerm/; Mathews et al. , 1 999;
Zuker et al. , 1 999) and a stem-loop with a stem of eight base pairs, a loop of four
nts, and a free energy value of -9. 1 kcal/mole was predicted (Fig. 2. 1 A). In the
minus strand, a stem-loop with an internal loop, a terminal hexaloop, and a free
energy of -3 .0 kcal/mole was also predicted (Fig. 2.2). The UGUG loop in the
positive strand does not belong to any identified family of especially stable
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Fig. 2.2. Integrity of stem III is required for DI RNA replication as determined by
analysis of mutant 1 variants of pDrep 1. The mfold-predicted structures of wt and
mutant transcripts of pDrepl (pSLIII-mutlL, pSLIII-mutlR, and pSLIII
mutlL/R) in the positive and negative strands, and their calculated free energies
in kcal/mole, are shown. The start codon for the intra-5' U TR ORF is boxed
(note that this moves 1 base position upstream in pSLIII-mutlL and pSLIII
mutlL/R relative to wt). Mutated bases are shown as lowercase letters. For
Northern analyses, T7 RNA polymerase-generated transcripts of linearized
plasmids were transfected into BCoV-infected cells and RNA was extracted at the
indicated times posttransfection and probed with a reporter-specific radiolabeled
oligonucleotide. Accumulation of mutant molecules was determined by
quantitative blotting of RNA harvested at the times indicated and at 48 h
postinfection with virus passage 1. Accumulation of pDrep1 progeny was
considered to be 1 00%. The sequence of the RNA in the progeny replicons was
determined by either bulk R T-PCR sequencing using pDrep I -specific primers as
described in the text, or by first cloning and then sequencing of plasmid DNA
from isolated colonies. Lanes: Uninf., mock infected, non-transfected cells; Inf.,
infected, non-transfected cells; RNA, sample of the transcript.
1
MACGRRFFIVVSIFISAVNSFQPG TCCILGSGPPIGHNVEDQQIRSR T TLGS
RISMDV. 2 Identical to the amino acid sequence predicted for mutant pSLIII-L
except that LG replace RR at positions 5 and 6.
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tetraloops (UNCG, GNRA, CUNG) (Varani, 1 995) suggesting it may not
contribute extraordinarily to stem-loop stability.
5' UTR sequences for 1 2 coronaviruses have now been reported enabling
comparisons of predicted higher-order structures ( see references associated with
GenBank accession numbers). For the eight members in group 2, BCoV-Mebus,
HCoV-OC43, HECoV-4408, HEV-67N, ECoV-NC99, MHV-2, MHV-A59, and
MHV-JHM, an mfold-predicted stem-loop III with small variations was found
(stem-loop III is identical in BCoV, HCoV-OC43 and HEV) (Fig. 2. 1 A) (Table
2.2). That is, there was predicted (i) a stem-loop III in the positive strand with a
stem (with or without an internal loop) of seven or eight nts, a terminal tetraloop,
and a net negative free energy within the range of -1 1 .5 to -5. 1 kcal/mole, (ii) a
stem-loop in the negative strand with a net negative free energy within the range
of -9.3 to -3.0 kcal/mole, and (iii) an AUG start codon for an ORF of 24 nts
beginning at the third or fourth base position in the stem of the positive strand.
The stem begins at base 96 for ECoV, 97 for MHV-A59 and MHV-2, and 1 0 1 for
MHV-JHM, and an internal loop occurs at the fourth base position in the stem for
all MHV strains and at the fifth base in ECoV. Although there is no evidence for
a conserved primary sequence among coronavirus groups 1 -3 in the region of
stem-loop III, mfold analyses of groups 1 and 3 revealed a possible stem-loop III
homolog in the same relative position within the 5' UTR (see Discussion).
Interestingly, all possess a closely-associated AUG start codon for a short intra-5 '
UTR ORF (Table 2.2). Thus, from folding predictions and evidence of
phylogenetic conservation it was postulated that stem-loop III in BCoV DI RNA
is a higher-order structure with possible function in RNA replication.
Enzyme structure probing supports the existence of stem-loop III in BCoV
RNA. Previous enzyme structure probing of the 5 '-terminal 262-nt region of the
BCoV genome had revealed, along with stem-loops I (nts 1 1 through 42) and II
(nts 5 1 through 84), a stem-loop III with an 8-base stem and a tetraloop (Chang et
al. , 1 996). Since RNA secondary structures can be significantly influenced by
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Table 2.2. Properties of predicted coronavirus intra-5' UTR stem-loop III, stem-loop III-associated ORF, and ORF-encoded
ligooeotid
- Coronavirus

N
-...J

Free energy of stemloop III in the
positive strand
(kcal/mole) 8

Free energy of stemloop III in the
negative strand
(kcal/mole)8

Kozak context
of the short
ORF start
codon

Predicted
number of amino
acids encoded by
short ORF

Amino acid sequence
of short ORF product

MLVGVDFS
UCUaugC
8
-3 .0
-9. 1
BCoVMebus
MLVGVDFS
UCUaugC
8
-3.0
HCoV-OC43 -9. 1
MPVGVDFS
UCUaugC
8
-6. 1
HECoV-4408 -1 1 .5
UCUaugC
MLVGVDFS
8
-3.0
-9. 1
HEV-67N
MLASLDFS
-4.2
UCUaugC
8
ECoV-NC99 -5. 1
MPAGLVLS
UCCaugC
8
-9.3
-9.0
MHV-A59
MPVGLVLS
-9.3
UCCaugC
8
-9.0
MHV-JHM
MPVGLVLS
UCCaugC
8
-8.6
-9.0
MHV-2
b
°
MKS
UCUaugA
-9.0
3
-12.9
TGEVPurdue
l lc
MAGIFDAGVVV C
-6.7b
GCUaugG
HCoV-229E - 1 7.4°
b
UGGaugG
MAPGHLSGFCY
-1 8.4b
11
-1 9.9
IBV-Beau.
M42
a. As determined by the Zuker algorithm.
b. For TGEV, HCoV-229E and IBV, the Zuker algorithm predicts a larger stem-loop than for the group 2 coronaviruses.
c. A second ORF beginning 1 6 nt downstream from the first encodes the amino acid sequence MLES.

flanking sequences, evidence for stem-loop III was reexamined in the context of a
595-nt transcript, in the present study. For this, 5'-terminal transcripts of Xba I
linearized pDrep l DNA were made and subjected to digestion with either single
strand-specific RNases T l (data not shown) or T2, or with double strand-specific
RNase CVl, and the products were analyzed by reverse transcriptase extensions
of 5 ' end-labeled primer SRDM(+) (Fig. 2. 1 B, lanes 1 -4 and 9- 13). Radiolabeled
products of an RNA sequencing reaction were analyzed in parallel to determine
sites of RNase digestion (Fig. 2. 1 B, lanes 5-8). The results show single- and
double-stranded regions in agreement with an mfo/d-predicted structure (Fig. 2. 1
C).
Integrity of stem III is required for BCoV DI RNA replication. To
examine the importance of the helical region in stem-loop III for DI RNA
replication, site-directed mutations in pDrep 1 predicted to disrupt and then restore
base-pairing with compensatory changes were made and transcripts were tested
for replication. A stem was deemed required for replication if helix-disrupting
mutations led to loss of accumulation (as determined by the absence of mutant
progeny molecules in VPl RNA) and structure-restoring compensatory mutations
led to some level of restored accumulation (as determined by the presence of the
double mutant progeny in VP l RNA). Analyses focused on DI RNA progeny in
VP I since (i) passaged (i.e., packaged) molecules should be free of long-lived
transfected mutant transcripts that would otherwise appear as progeny in RT-PCR
assays, and (ii) Northern assays alone do not discriminate between replicating
mutant and replicating (recombination-derived revertant) wt molecules.
In earlier studies, a set of mutants, pSLIII-mutlL and pSLIII-mutlR were
made in which four of the eight base-pairs were disrupted in each the left and
right arms, and a double mutant pSLIII-mut 1 L/R in which stem III is restored was
made, and replication of these mutants was studied using Northern assays
(Bouma, 1 997).
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In the present study, the replication assay of mutants pSLIII-mut l L,
pSLIII-mutl R, and pSLIII- mutl L/R was repeated. Mutants pSLIII-mut l L and
pSLIII-mut l R had stem-loop III free energy values of -2.2 and -1 .7 kcal/mole in
the positive strands, respectively, and no predicted structures in the negative
strands (Fig. 2.2). By Northern analysis of mutants pSLIII-mut l L and pSLIII
mut l R, 6% or less of wt levels of RNA had accumulated by 24, and <1 % 48 hpt
and by 48 hpi in VP l . Sequence analysis of asymmetrically amplified cDNA
from VP I RNA showed the products of both mutants pSLIII-mut l L and pSLIII
mut l R to be revertants to wt and thus the mutants had not replicated. By contrast,
accumulation of progeny from double mutant pSLIII -mutl L/R for which the free
energy value had become -8.8 kcal/mole in the positive strand and -3 .0 kcal/mole
in the negative strand was 1 4% of wt levels in VP 1 , and asymmetrically- amplified
cDNA from progeny molecules in VP I , as well as in cDNA clones of these,
showed progeny to be a mixture of wt and double mutant sequences (Fig. 2.2). Of
8 clones sequenced, 2 were wt and 6 were the SLIII-mutl L/R mutant. cDNA
from VP2 also showed a mixture of wt and mutant sequences indicating continued
replication of the double mutant through a second virus passage. These results
together indicate that the helical region of stem- loop III either in the positive or
negative strand or both is a requirement for DI RNA replication. A lower rate of
accumulation in the double mutant than in wt, however, suggested that factors
other than the helical nature of the stem, perhaps the stability of the stem, the
nucleotide sequence within the stem, the size and location of the stem- loop
associated ORF, or the ORF product, might also be important for maximal
accumulation.
To test for the requirement of the stem under conditions that would
minimally disrupt the short ORF, a second set of three mutants was examined in
which the short ORF product differed from wt by no more than three amino acids
(Fig. 2.3). In pSLIII-mut2L, five of the eight bases in the left arm were changed
leaving only those in the wt l 00AUG codon unchanged and increasing the free
energy value in the positive strand to +0.9 kcal/mole and leading to no predicted
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Fig. 2.3. Integrity of stem III is required for DI RNA
replication as determined by analysis of mutant 2 variants of
pDrepl . The assays were carried out as described in Fig. 2.2
except that mutant variants (pSLIII-mut2L, pSLIII-mut2R,
and pSLIII-2L/R) were used.
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structure in the negative strand. The changes altered only the second amino acid
(L

➔ G) yielding a potential oligopeptide product of MGVGVDFS.

In pSLIII

mut2R, five nucleotides in the right arm were changed maintaining the 1 1 1 CGU
base-pairing partner with l 00AUG, increasing the free energy in the positive
strand to +2.3 kcal/mole and leading to no predicted structure in the negative
strand, and potentially encoding an oligopeptide product of MLV.S.VLFS. In the
double mutant pSLIII-mut2L/R, the calculated stem-loop III free energy was
- 1 0.0 kcal/mole in the positive-strand, -3 .2 kcal/mole in the negative-strand, and
the potential ORF product, MGV.SVLFS. Northern analyses of progeny from
pSLIII-mut2L and pSLIIl-mut2R showed an accumulation of <1 % of wt levels at
24 and 48 hpt and in VP 1 , and sequence analyses of asymmetrically-amplified
cDNAs showed progeny to be all revertant wt molecules indicating the mutants
had not replicated. On the other hand, accumulation of progeny from the double
mutant pSLIII-mut2L/R was > 26% of wt levels at 24 and 48 hpt and >2% in VP 1 ,
and all progeny in VP 1 had retained the mutant sequences. Thus, these results are
consistent with the experiment described in Fig. 2.2 and suggest that stem- loop III
either in the positive or negative strand, or both, is required for replication. A less
than wt level of accumulation for the double mutant, however, would suggest
again that perhaps the nt sequence within the stem or possibly the amino acid
sequence of the short ORF product were not optimal for maximal accumulation.
The notion that the nt sequence within the stem or the amino acid
sequence of the ORF product are important factors in accumulation in the context
of an otherwise stable stem was supported by results from mutants in which single
base changes were made in the upper part of the stem. In mutant pSLIII -

mutG 1 09 ➔ A a stem of 8 nts was predicted for which the free energy of stem
loop III became -9.0 kcal/mole in the positive strand, --4.2 kcal/mole in the
negative strand, and the potential ORF product became MLV.SVDFS, and in
pSLIII -mutG 1 1 o ➔ A a stem of 7 nts was predicted for which the free energy of
stem-loop III became -4. 1 kcal/mole in the positive strand, - 1 .0 in the negative
strand, and the potential ORF product became MLVDVDFS (Fig. 2.4 A and B).
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Fig. 2.4. Importance of stem III for DI RNA replication independent of the
potential short ORF product. The importance of stem III in the presence of little
(A and B) or no (C) change in the potential short ORF product was measured by
assays described in Fig. 2.2. A. Accumulation and sequence of progeny from wt,
or mutant transcripts bearing a mutation at base 1 09 (pSLIII-mutG 1 09 ➔ A). B.
Accumulation and sequence of progeny from wt, or mutant transcripts bearing a
mutation at base 1 1 0 (pSLIIO -mutG 1 1 o ➔ A). C. Accumulation and sequence of
progeny of wt, or mutants with changes at codon wobble positions that maintain
the wt ORF product MLVGVDFS. Stem III was maintained in pSLIII-mut5 but
disrupted in transcripts of pSLIII-mut6. Assays were carried out as described in
Fig. 2.2.
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For these, although only mutant sequences were found in VPl DI RNA,
accumulation was still less than maximal in that only 4 7 and 9 % of wt levels,
respectively, were found in VPl . Thus, to evaluate the role of stem-loop III
integrity in mutants that contained nt changes but still produced a potential wt
short ORF product, double mutants were made by changing bases in codon
wobble positions such that a wt ORF product was retained but that the stem was
either maintained or disrupted. For these, pSLIII-mut5 was made in which stem
III was maintained in both the positive (-8.7 1 kcal/mole) and negative (-2.6
kcal/mole) strands, and pSLIII-mut6 was made in which no structure was
predicted in either strand of stem-loop III (Fig. 2.4 C). Accumulation of pSLIII
mut5 progeny was no less than that of wt DI RNA at all time points and the
sequence of VP 1 progeny were all mutant molecules indicating the stable stem
mutants potentially producing a wt ORF product replicated at least as well as wt
stem-loop III. On the other hand, accumulation of pSLIII-mut6 in which no stem
loop III structure was predicted was at less than wt levels and only 1 5% of wt
levels were produced in VP 1 for which all progeny had wt sequence. These
results together demonstrate that the integrity of stem-loop III is important for
replication independent of any effect of the short ORF product, and that at least
some nucleotide changes in the stem are well tolerated.
Replication of BCoV DI RNA shows a strong preference for the presence
of a stem-loop III-associated short ORF. An association of an AUG-initiated
short ORF with stem-loop III (or its presumed homolog) in all coronaviruses (see
Discussion) led us to hypothesize that the short ORF plays a role as a cis-acting
element in replication. To test whether it does, the DI RNA was modified in ways
that were predicted to either diminish or prevent translation of the ORF but
minimally perturb the integrity of stem-loop III. In the first modification, pSLIII
mut3 L was made in which l 00AUG was changed to l 00AcG, a threonine codon
known to function inefficiently as a translation start codon (Peabody, 1 989) (Fig.
2.5 A). In this construct it was predicted by mfold that base-pairing in the positive
34

A

Plus
strand

pDrep1 _
91
G U
U G
U-G

!g

G
mut3L u-A

C-G
- U-A-

Plus
strand

pDrep 1

-9. 1

(wt)

pSLIIImut4UR

[
[

Minus ]
strand
-3.0

!�

C A
A C
A C
G-C
C-G

-9.3

-7.4

G U

u

G
U-G

a

U-A
C-G
- U-A-

z
er::

]

<(

z

er::

.....

a.

>

.r:.

"'

'11!

,

<(

-9. 6

·10.9

B

<

C A
A
C
A
C
G-C
C-G
g-C
0-A
A-U
G-C
-A-U-

C

z
er::

•

-3.0

(wt)

pSLI I I-

<(

[ Minus ]
strand

\

•

Predicted
short ORF
product

wt

MLVGVDFS

both wt
and
mutant

ILVGVDFS

1 00% 1 00% 1 00% 1 00%
.r:.

.r:.
v
N

.r:.
co
v

1 01 % 1 46%

60%

.....

a.

>
1 8%

• ...
.r:.

.r:.

.r:.
co

v
N

v

a:>

,

nt seq.
in VP 1

Predicted
short ORF
product

wt

MLVGVDFS

1 00% 1 00% 1 00% 1 00%

<(

z

.r:.

er::

.r:.

v
N

.r:.
co

v

.....

a.

>

u-a
a-u

A-U
G-C
-A-U-

n t seq.
in VP 1

89%

1 2%

3%

<1%

40%wt;
40% 1 00AUG,
1 1 1CGa;
20% 1 00AaG,
1 1 1 CGa

none

Fig. 2.5. A stem-loop III-associated short ORF correlates with
maximal DI RNA accumulation. A. Accumulation and
sequence of progeny from DI RNA in which the stem-loop III
associated short ORF begins with an AcG threonine codon
(pSLIII-mut3L). The sequence of progeny in VP l was
determined to be a mixture by sequencing the asymmetrically
amplified R T-PCR product. B. Accumulation and sequence of
mutant transcripts in which the stem-loop III-associated short
ORF begins with a uaG stop codon (pSLIII-4L/R). The
sequence of progeny molecules in VP 1 was determined from
clones of the R T-PCR product. Assays were carried out as
described in Fig. 2.2.
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strand would be maintained between the AcG codon and the cognate wt triplet
111CGU, and that the negative free energy of stem-loop III would increase to
-10.9 kcal/mole in the positive strand and increase approximately three-fold to
-9.6 kcal/mole in the negative strand. By Northern analysis, accumulation of
transcripts in VPl was 18% of wt, and the sequence of the replicating progeny in
VP l was a mixture of both wt and mutant indicating that some of these mutants
had replicated. Progeny in VP2 were all wt. These results indicated that
transcripts with an AcG-initiated short ORF can be replicated but with less
efficiency than wt DI RNA and that an AUG-initiated ORF is preferred.
To test the importance of the short ORF by another approach, pSLIII
mut4L/R was made in which the l00AUG was changed to a l00uaG stop codon
and its cognate base-pairing triplet was changed from 111CGU to 111Cua to
maintain full base pairing in the stem (Fig. 2.5 B). In pSLIII-mut4L/R, the mfo/d
predicted stem-loop III had a free energy of -9.3 kcal/mole in the positive strand,
-7.4 kcal/mole in the negative strand, and no predicted ORF product. Whereas
Northern analysis showed an accumulation of <1% of wt after VPl , sequence
analysis of asymmetrically-amplified cDNA of progeny at VPl revealed a
mixture of l O0A(U,a)G and 111C(G,u)(U,a). Thus, the cDNA products were
cloned and sequenced to resolve the makeup of progeny molecules. Of 13 clones,
5 were wt sequence, 3 showed l00AUG but with a cognate base-pairing 11 lCGa
triplet (potentially encoding the peptide MLVG1;DFS), and 5 showed 1 00AaG
(known not to function as a start codon [Peabody, 1989]) with a cognate 111CGa
triplet. No clones had the sequence of the original mutations of 100uaG or
111Cua. All progeny in VP2 were wt as determined from sequencing
asymmetrically-amplified cDNA. These results, therefore, established that
molecules with the non-start codon AaG had replicated poorly and those with a
uaG non-start codon had not replicated indicating, as did the experimental results
with mutant pSLIII-mut3L (Fig. 2.5 A), that there is a preference by the DI RNA
for a l 00AUG-initiated short ORF in replicating molecules.
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DISCUSSION
In this study, we present evidence that supports the existence of a
predicted stem-loop III mapping at nts 97 through 116 in the 210-nt long 5' UTR
of the BCoV genome and show through mutagenesis analyses that the stem of this
structure is required for the replication of BCoV DI RNA. Stem-loop III has an
associated AUG that begins an intra-5' UTR ORF of 24 nts, and mutagenesis
studies of this suggested its maintenance is preferred by the DI RNA for
replication. The short ORF or its product, therefore, may act to enhance
replication. Comparison of 5' UTR sequences of eight group 2 coronaviruses
revealed that stem-loop III and the associated ORF are largely conserved in
position and structure. Is a stem-loop III also found in the other coronavirus
groups? Mfold analyses of the 5' UTR sequences of the group 1 coronaviruses
HCoV-229£ and TGEV (for recently sequenced group 1 coronavirus PEDV see
Appendix), and the group 3 coronavirus IBV, indicated that a bulged stem-loop
III analog, if not homolog, of approximately twice the size with an associated
intra-5'UTR ORF is positioned similarly within the 5' UTR (Fig. 2.6). (For
recently sequenced HCoV-SARS see Appendix). Except for HCoV-229E, the
predicted loop is also a tetraloop (in HCoV-229£ it is a three base loop) and in all
cases the AUG codon for the associated intra-5' UTR ORF is within the stem
(Fig. 2.6, Table 2.2). ORF-encoded oligopeptides range from 3 amino acids (aa)
in length in TGEV to 11 aa in IBV and appear to be dissimilar in sequence (Table
2.2).
From experiments described here it was not established how stem-loop III
or the ORF function mechanistically in DI RNA replication. However, several
questions approaching mechanism are raised. (i) Does stem-loop III function in
the positive or negative strand, or both? Since base-pair covariations among
group 2 members maintain stem-loop III in the negative strand (free energy range,
-9.3 to -3.0 kcal/mole) as well as positive strand (-11.5 to -5.1 kcal/mole) (Table
2.2), the possibility exists that stem-loop III functions in either strand, or both.
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Fig. 2.6. Potential stem-loop III homologs in coronavirus groups
I and 3 are predicted by the Zuker mfold algorithm. AUG
codons for potential stem-loop-associated ORFs are boxed. In
HCoV-229E the second AUG is in the + 1 frame relative to the
first ORF.
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The question was not answered by our experiments since net negative free energy
values were maintained in both the negative- (-4.2 to - 1 .0 kcal/mole) and positive
(- 1 0.9 to -4. 1 kcal/mole) strand stem-loop III structures in all mutants that
replicated. (ii) What trans-acting factors, if any, bind stem-loop III? Precedents
in other plus-strand RNA viruses (Barton et al. , 200 1 ; Frolov et al. , 200 1 ;
Gamarnik et al. , 1 998; Herold et al. , 200 1 ; Teterina et al. , 200 1 ; and references
therein) lead us to speculate that stem-loop III most likely binds viral or cellular
protein(s) in the positive-strand. This would be consistent with studies showing
translation of an ORF attached to the genomic 5' UTR of BCoV to be regulated
differently in infected and uninfected cells (Senanayake et al. , 1 999). However, a
cellular protein of 55 kDa has been found to bind to nts 56 through 1 1 2 in the
MHV-JHM 5' genome terminus, and cellular proteins of 35 and 3 8 kDa to bind to
the minus- strand counterpart of this sequence (Furuya et al. , 1 993 ). Since this
sequence represents the upstream half of stem-loop III, these proteins become
candidates for playing a role in stem-loop III function. Preliminary experiments
in our laboratory have indicated that viral and cellular proteins bind the positive
strand form of stem-loop III whereas only cellular proteins bind the negative
strand form (S. Raman and D. Brian, unpublished; Chapter III). Thus the
interactions of stem-loop III with trans-acting elements of either protein or RNA
need to be further examined. (iii) Do the bases in the loop of stem-loop III serve a
specific function? Inasmuch as loops (terminal and internal) and bulges within
RNA often function as protein binding sites (Nowakowski et al. , 1 997), the
function of the terminal loop sequence will need to be evaluated. (iv) Does the
intra-5 ' UTR ORF affect replication through a cis-acting influence on translation?
Several short upstream ORFs have now been shown to profoundly influence the
translation of downstream ORFs in eukaryotic and viral RNAs through a variety
of mechanisms (Gabelle, 1 996; Mathews, 1 996; Morris et al. , 2000). Inasmuch as
the replication of some group 2 DI RNAs show a cis-preference for translation
(Chang et al. , 1 996; van der Most et al. , 1 995), a parallel may exist in genome
replication. If so, the influence of a genomic upstream ORF may significantly
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affect genome replication. Certainly, a short intraleader ORF in a mutant BCoV
genome that arose during persistent infection in cell culture had a measurable
effect on the translation from an ORF 1 start codon in vitro (Hofmann et al. ,
1 993). Curiously, none of the stem-loop III-associated ORFs begin within a
highly favorable Kozak context (Kozak, 1 994; Table 2.2) suggesting that
translation from this ORF may not need to be efficient to fulfill a translational
requirement. In addition, our results showing that at least some molecules with a
totally foreign short ORF (i.e., the ORF beginning at nt 99 in pSLIII-mutl L/R in
Fig. 2.2) can replicate indicates that perhaps any ORF and not necessarily only the
wt ORF can suffice. In this regard, it would seem possible that an inefficient start
codon such as CUG (Peabody, 1 989) at position 91 (Fig. 2.1 ), which is in frame
with the wt short ORF, could suffice for replication and maybe this is what
initiates the ORF function for the replicating progeny of mutant pSLIII-mut4L/R
in which a non-start AaG (lys) codon is found at position 100 (Fig. 2.5 B). If this
is true, then perhaps the function of the short ORF in replication is necessary and
not just preferred for replication. In this regard, it is also curious that a short 5'
UTR-positioned ORF in the equine arteritis virus appeared to have no effect on
the replication of this Nidovirus in cell culture (Molenkamp et al. , 2000). It is a
remote possibility, suggested by the results of our experiments with the AcG
codon, that a weak start codon such as GUG (Peabody, 1 989) used in the equine
arteritis virus experiments (Molenkamp et al. , 2000) could have sufficed to
initiate a required translation function of the short ORF. (v) Does stem-loop III
function as a packaging signal? Inasmuch as our assay measured the character of
VPl (packaged) molecules, our results would have been influenced by a
packaging function of stem-loop III. Thus, despite the mapping of a BCoV
packaging signal within ORF 1 b at genome nt positions 20,049-20, 1 1 7
(Chouljenko et al., 2001 ; Cologna et al. , 2000; and K. Nixon and D. Brian,
unpublished data), a sequence not present in the BCoV DI RNA studied here, the
role of stem-loop III in DI RNA packaging should be examined. It should be
noted, however, that with no mutant did we see abundant accumulation at 24 and
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48 hpt and a low accumulation in VP 1 making it unlikely that a disrupted
packaging signal explains the low levels in VP l observed in Figs. 2. 1 and 2.2.
The question of what constitutes the cis-acting elements for coronavirus
RNA replication is especially relevant to an earlier postulate that coronavirus
subgenomic (sg) mRNAs behave as replicons in the presence of trans-acting viral
RdRp (Sethna et al. , 1 989). Whereas the postulate is consistent with the
observations that (i) the termini on sgmRNAs are theoretically large enough to
serve as RdRp promoters for replication (a 5'-terminal region of 65 to 95 nts and a
3'-terminal region of ~300 nts [Cavanagh, 1 997; Lai et al. , 1 997; van der Most et
al. , 1 995]) (both of which greatly exceed the sizes of alphavirus and myxovirus

replication promoters [Levis et al. , 1 986; Li et al. , 1 992]), (ii) coronavirus
sgmRNAs have minus-strand counterparts (Hofmann et al. , 1 990; Sethna et al. ,
1 991 ; Sethna et al. , 1 989) capable of forming mRNA-length, double - stranded
(apparent) replicative intermediates (Barie et al. , 1 987; Barie et al. , 2000;
Hofmann et al. , 1 990; Sawicki et al. , 1 990; Sawicki et al. , 1 995; Sawicki et al. ,
2001 ; Sethna et al. , 1 997; Sethna et al. , 1 991 ; Sethna et al. , 1 989), and (iii)
sgmRNAs accumulate faster than genome at early times after infection (Hofmann
et al. , 1 990; Sethna et al. , 1 989), the hypothesis has not been supported by

experiments that directly measure sgmRNA accumulation following transfection
into helper virus-infected cells (Chang et al. , 1 994; Makino et al. , 1 99 1 ). For
BCoV, the replicating DI RNA differs from sgmRNA 7 by only 42 1 nts, the first
1 3 7 of which come from nts 74 through 2 1 0 in the genomic 5 ' UTR and the
second 284 of which come from the 5 ' end of ORF l a (Chang et al. , 1 994).
Assuming mRNAs do not replicate as indicated by the results of transfection
experiments (Chang et al. , 1 994; Makino et al. , 199 1 ), then elements mapping
within the 5 '-proximal 42 1 nts in BCoV DI RNA but absent in subgenomic
mRNAs must be providing at least part of what is needed for replication. Stem
loop III described here appears to be one of these elements.
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CHAPTER III. VIRAL AND CELLULAR PROTEIN
INTERACTIONS WITH STEM-LOOP III IN THE BOVINE
CORONAVIRUS GENOMIC 5' UNTRANSLATED REGION.

INTRODUCTION
5'-proximal cis-acting elements required for bovine coronavirus (BCoV)
defective interfering (DI) RNA replication have been shown to includ� two
higher-order structures identified as stem-loops III (Chapter II; Raman et al.,
2003) and IV (Chapter IV) mapping mostly within the 5' untranslated region (5'
UTR). Stem-loop III shows phylogenetic conservation as an element in group 2
coronaviruses, has a possible analog if not homolog in coronavirus groups 1 and
3, and has associated with it in all coronaviruses for which sequence is known a
short intra-5' UTR open reading frame (Chapter II; Raman et al., 2003). A stem
loop III analog with these properties appears in the SARS coronavirus genome as
well (Raman and Brian, unpublished; Appendix). The higher-order structure of
stem-loop III was shown to be required for DI RNA replication and the stem-loop
III-associated intra-5' UTR was shown to enhance DI RNA accumulation but not
to be an absolute requirement for replication (Chapter II; Raman et al., 2003).
The potential for stem-loop III to bind proteins has not been reported. Stem-loop
IV has been shown to function as a higher-order structure in the positive strand
and to bind as a higher-order element eight cellular proteins in the molecular
weight range of 75 to 25 kDa molecular weight (Chapter IV).
Few studies have described the association of viral or cellular proteins
with the 5' UTR of coronavirus genomic RNA. One characterized interaction is
that of viral nucleocapsid (N) protein with leader sequence in MHV-JHM (Nelson
et al., 2000; Stohlman et al., 1988). Its strong interaction, a measured Kd of 14
nM, was shown to be dependent on the leader-associated AAUCYAAAC
sequence mapping at nts 68 through 76, and cellular mRNAs with this binding
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region experimentally engineered into the 5 ' UTR experienced an advantage in
translation over cellular mRNAs lacking this sequence in MHV - infected cells
(Nelson et al., 2000; Stohlman et al., 1 988). The binding region for this
interaction within the 455 amino-acid N protein mapped at amino acid residues
1 77 through 23 1 (Nelson et al., 2000). In MHV-JHM, a 55 kDa cellular protein
has been found to bind nts 56 through 1 1 2 in the genomic 5 ' UTR and cellular
proteins of 3 8 kDa and 3 5 kDa bind to the minus-strand counterpart of this
sequence (Furuya et al., 1 993). This region includes the upstream 1 5 nts of the
20-nt stem-loop III in MHV-JHM and could theoretically form a part of stem- loop
III with a three base-paired stem and a free energy of -4.0 kcal/mole in the
positive-strand and -4. 1 kcal/mole in the negative-strand. To our knowledge no
description has yet been made for any coronavirus of viral proteins binding to the
5 ' UTR in the region encompassed by stem-loop III.
Here, we extend our earlier studies on stem-loop III in the BCoV DI RNA
(Chapter II; Raman et al., 2003) to determine in which strand, positive or
negative, it functions in replication, and whether proteins if any interact with the
active structure(s). We present data showing (i) that stem-loop III functions in
both the positive and negative-strand orientations, (ii) that viral N protein, and
another viral protein or virally induced or modified cellular protein of
approximately 22 kDa molecular weight specifically bind stem- loop III in the
positive strand in a higher-order structure-dependent manner, and (iii) that seven
cellular proteins in the molecular weight range of 76 to 25 kDa specifically bind
stem-loop III in the negative strand in a higher-order structure-dependent manner.

MATERIALS AND METHODS
Virus and Cells. A DI RNA-free stock of the Mebus strain of BCoV at 4.5
X 1 08 PFU/ml was prepared and used as a helper virus as previously described
(Chang et al., 1 994; Raman et al., 2003). The human rectal tumor cell line HRT-
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18 (Tompkins et al., 1974) was used as previously described (Chang et al., 1994;
Raman et al., 2003).
Plasmid constructs. Construction of pGEM3Zf(-) (Promega)-based pDrep
1 (Chang et al., 1 994) and its stem-loop III mutant derivatives pSLIIl-mut2L,
pSLIII-mut2R, pSLIII-mut2L/R, and pSLIII-mut4L/R (Table 3. 1 ) have been
previously described (Chapter II). To construct the additional mutant derivatives
used in this study, overlap PCR mutagenesis (Horton et al., 1 990) was used with
plasmid DNA and the oligonucleotides described in Table 3.2. The strategy for
constructing the mutants was the same as that used for pSLIII-mutGU except for
the differences noted. For making pSLIII-mutGU, primers Ndel (+), SRST3GU(
), and pDrep l DNA were used in the first PCR, primers SRST3GU(+), GEM3Zf(
)Nde l (-), and pDrepl DNA were used in the second PCR, and primers GEM3Zf(
)Nde l (-) and Ndel (+) and the products of the first two reactions were used in a
third PCR to make a 1 , 1 83-nt product that was trimmed to 693 nts with restriction
endonucleases NgoM IV and Avr II and cloned into NgoM IV/Avr II-linearized
pDrepl . For making pSLIII-mutCA, SRST3CA(-) replaced SRST3GU(-) in the
first PCR, and SRST3CA(+) replaced SRST3GU(+) in the second PCR.
For making pSLIII(PB), a construct from which 1 20-nt T7 RNA
polymerase-generated transcripts of wt positive-strand stem-loop III-containing
RNA for protein binding studies can be made, a three step procedure was used:
(i) An EcoR V restriction endonuclease site was engineered at nt 3 in pDrep 1 to
create pDrepEcoRV3. For this, overlap PCR mutagenesis was used in which
Nde l (+), SRECOR5(-) and pDrep l DNA were used in the first PCR,
SRECOR5(+), GEM3Zf(-)Ndel (-) and pDrepl DNA were used in the second
PCR, and GEM3Zf(-)Ndel (-), Nde l (+) and the products of the first two reactions
were used in a third PCR to make a 1 , 183-nt product that was trimmed to 693 nts
with restriction endonucleases NgoM IV and Avr II and cloned into NgoM
IV/Avr II-linearized pDrepl . (ii) A second EcoR V restriction endonuclease site
was engineered at nt 65 to create pDrepEcoRV65. For this, the same strategy was
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Table 3 . 1 . S

Mutant
name in
plasmid8

�

Vl

- f BCoV st

- III mutant

Sequence in stem-loop III mutant
positive strand b

Property of stem-loop III
mutant

kcal/
mole
in (+)
strande

kcal/
mole
in (-)
strande

Replication d

Number of UV
crosslinked protein
bandse
Cellular

Viral

pSLIII
-UCUAUGCUUGUGGGCGUAGA- wt
-9. 1
-3 .0
yes
3
2
(wt)
-UCUAUGuUUGUGGGCGUgGgStem-loop retained in (+)
pSLIIIno
no
3
-5.4
2
but not (-) strand.
mutGU
struct.
-cCcAUGCUUGUGGaCGUAGAStem-loop retained in (-)
pSLIII-0.9
no
no
0
3
but not (+) strand.
mutCA
struct.
-agaAUGggUGUGGGCGUAGAStem is disrupted in (+)
pSLIIIno
no
0
3
no
and (-) strands.
mut2L
struct. struct.
Stem is disrupted in (+)
-UCUAUGCUUGUGucCGUucupSLIIIno
4
no
no
2
and (-) strands.
mut2R
struct. struct.
-agaAUGggUGU GucCGUucuStem is re-formed in ( +)
pSLIII- 1 0.0 -3. 2
3
yes
2
and (-) strands.
mut2L/R
AUG in stem changed to
-UCUuaGCUUGUGGGCuaAGApSLIII-9.3
no
-7.4
2
3
UAG
mut4L/R
-UCUAUGCUUGUGucCGUuugUc- Stem III and alternate stem no
pSLIIINIA
no
4
0
are disrupted.
mut3R
struct. struct.
a. Mutants of stem-loop III in BCoV DI RNA examined in Chapter II and in this study. Throughout the text wild type and
mutants are abbreviated wt, mutGU, mutCA, mut2L, mut2R, mut2L/R, mut4L/R, mut3R. T7 RNA polymerase-generated
transcripts of these plasmids yield 223 1 -nt transcripts that are tested for their ability to replicate after transfection into BCoV
infected cells.

Table 3.1. Continued .
b. Represents nts 97-116 in BCoV DI RNA, except for mutant pSLIII-mut3R in which the sequence represents nts 97-118. The
underlined AUG is the start codon for the intraleader short ORF.
c. Free energy calculated for the stem-loop via the Zuker algorithm.
d. Said to be replicating if the mutant form is present in cells infected with passage one virus following transfection. Replication
studies of mutants mut2L, mut2R, mut2L/R, and mut4L/R were described in Chapter II.
e. Determined in this study.
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Oligonucleotide8 Polarity Sequence (5'->3't

+

GAGAGTGCACCATATGCGGTGT

-

+

CCTCCAAATCATATGGACGTGTATTC
CCACTCCCTGTATTCTATGtTTGTGGGCGTgGgTTTTTCATAGTGGTGTC
GACACCACTATGAAAAAcCcACGCCCACAAaCATAGAATACAGGGAGTGG
CATCCACTCCCTGTATcCcATGCTTGTGGaCGTAGATTTTTCATAGTGG
CCACTATGAAAAATCTACGtCCACAAGCATgGgATACAGGGAGTGGATG
GTGAATTGTAATACGACTCACTATAGATatcGAGCGATTTGCGTGCGTGC

SRECOR5(+)

-

GCACGCACGCAAATCGCTCgatATCTATAGTGAGTCGTATTACAA TTCAC

SRECORV70(-)
SRECORV70(+)
SRleader(-)
SRST3double(-)
SRST3double(+)
SRST3L(-)
SRST3L(+)
SRST3R(-)
SRST3R(+)
SRST3RALT(-)
SRST3RALT(+)

+

GEM3Zf(-)
Nde l (-)
Nde l (+)
SRST3GU(-)
SRST3GU(+)
SRST3CA(-)
SRST3CA(+)
SRECOR5(-)
�
-....J

+

-

+

-

-

+
+

-

+

-

+

-

+

-

Binding
region
in
pDrepl
249825 1 9 c

456-4 8 1
84- 1 33
84- 1 3 3
8 1 - 1 29
8 1 - 1 29
3 1 75 c

25
3 1 75 c 25
GATCTCTTGTTAGATCTTTTTATAgatatcACTTTATAAAAACA TCCACTCCCTG
39-93
CAGGGAGTGGATGTTTTTATAAAGTgatatcTATAAAAAGATCTAACAAGAGATC 39-93
GATTGTGAGCGATTTGCGTGCGTGC
1 -25
CACTCCCTGTATagaATGggTGTGtcCGTtct
85- 1 1 6
agaACGgaCACAccCATtctA TACAGGGAGTG
85- 1 1 6
CACTCCCTGTATagaATGggTGTGGGCGTAGA
85- 1 1 6
TCTACGCCCACAccCATtctATACAGGGAGTG
85- 1 1 6
GTATTCTATGCTTGTGtcCGTtctTTTTTCATAGTGG
93- 1 29
CCACTATGAAAAAagaACGgaCACAAGCATAGAATAC
93- 1 29
GTATTCTATGCTTGTGtcCGTttgTcTTTCATAGTGG
93- 1 29
CCACTATGAAAgAcaaACGgaCACAAGCATAGAATAC
93- 1 29

Table 3 .2. Continued.
Oligonucleotide8 Polarity Sequence (5'->3'l

Binding region in
pDrepl
SRUTRSTOP(-)
+
84- 1 28
CCACTCCCTGTA TTCTtaGCTTG TGGGCtaAGATTTTTCATAGTG
SRUTRSTOP(+)
CACTATGAAAAA TCTtaGCCCACAAGCtaAGAA TACAGGGAGTGG 84- 128
TGEV8(+)
1 098- 1 1 23
CATGGCACCATCCTTGGCAACCCAGA
TGEV8b(+)
CATGGCACCATCCTTGGCA
1 1 05 - 1 1 23
a. The positive and negative symbols in the oligonucleotide names indicate the polarity of the nucleic acid to which the
oligonucleotide anneals .
b. Lowercase bases represent mutated sites.
c. Indicates nucleotide positions in the pGEM3Zf(-) vector.
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used except that SRECORV70(-) replaced SRECOR5(-) and pDrepEcoRV3 DNA
replaced pDrep 1 DNA in the first PCR, and SRECORV70(+) replaced
SRECOR5(+) and pDrepEcoRV3 DNA replaced pDrep l DNA in the second
PCR. (iii) pDrepEcoRV65 DNA was digested with EcoR V to remove nts 4
through 65 and the ends of the remaining fragment were ligated resulting in
pSLIII(PB). In construct pSLIIl(PB), wild type nts 66UAA were changed to
66AUC.
The strategy for constructing each of the following mutants from which
1 20-nt T7 RNA polymerase-generated transcripts can be made was the same as
that used for pSLIII-mut2L(PB) except for the differences noted. For making
pSLIII-mut2L(PB), primers Nde l (+), SRST3L(-), and pSLIII(PB) DNA were
used in the first PCR, primers SRST3L(+), GEM3Zf(-)Ndel (-), and pSLIII(PB)
DNA were used in the second PCR, and primers GEM3Zf(-)Nde l (-) and Nde l (+)
and the products of the first two reactions were used in the third PCR to make a
1 , 1 2 1 -nt product that was trimmed to 63 1 nts with restriction endonucleases
NgoM IV and Avr II and cloned into NgoM IV/Avr II-linearized pDrepl . For
making pSLIII-mut2R(PB), SRST3R(-) replaced SRST3L(-) in the first PCR, and
SRST3R(+) replaced SRST3L(+) in the second PCR. For making pSLIII
mut2L/R(PB), SRST3double(-) replaced SRST3L(-) and pSLIII-mut2R(PB) DNA
replaced pDrep l DNA in the first PCR, and SRST3double(+) replaced
SRST3L(+) and pSLIII-mut2R(PB) DNA replaced pDrepl DNA in the second
PCR. For making pSLIII-mut4L/R(PB), SRUTRSTOP(-) replaced SRST3L(-) in
the first PCR, and SRUTRSTOP(+) replaced SRST3 L(+) in the second PCR. For
making pSLIII-mutGU(PB), SRST3GU(-) replaced SRST3L(-) in the first PCR,
and SRST3GU(+) replaced SRST3L(+) in the second PCR. For making pSLIII
mutCA(PB), SRST3CA(-) replaced SRST3L(-) in the first PCR, and
SRST3CA(+) replaced SRST3L(+) in the second PCR. For making pSLIII
mut3R(PB), SRST3RALT(-) replaced SRST3L(-) in the first PCR, and
SRST3RALT(+) replaced SRST3L(+) in the second PCR.
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For making pSLIII-minus(PB), pSLIII-mutGUminus(PB) and pSLIII
mutCAminus(PB) from which 130-nt SP6 RNA polymerase-generated negative
strand stem-loop III-containing transcripts can be made, pSLIII(PB), pSLIII
mutGU(PB), and pSLIII-mutCA(PB), respectively, were digested with Hpa I and
Miu I to remove nts 153 through 2,231 and the ends of the remaining fragments
were ligated.
Northern assay for DI RNA replication. The Northern assay was
performed as previously described (Chapter II).
Sequence analysis of the stem-loop III region in progeny DI RNAs. For
direct sequencing of asymmetrically-amplified cDNA, the procedure as described
by Hofmann et al (Hofmann et al., 1993) for analysis of plus-strand RNA was
used as previously described (Chapter II). Briefly, oligonucleotides TGEV8b(+)
and SRleader(-) were used for RT-PCR with RNA extracted at 48 hpi from cells
infected with the first passage virus (VPl ), and 5'end-radiolabeled
oligonucleotide SRleader(-) was used for sequencing.
RNA-protein binding assays. Preparation of cell lysates and the
electrophoretic mobility shift assays (EMSAs) essentially followed the procedures
of Gamamik and Andino (Andino et al., 1990; Gamamik et al., 1997). The
method for probe elution from preparative gels was that of Thomson et al
(Thomson et al., 1999). For preparation of cell lysate, freshly confluent HRT
cells (~1.2X106 cells per 35mm dish) were either mock infected, or infected with
BCoV at a multiplicity of 10 PFU per cell, and processed as individual plates.
Cells were washed and harvested at 6 hours post infection (or equivalent time in
mock-infected cells) in ice cold phosphate buffered saline (PBS) by scraping and
centrifuging at 600 X g for 4 minutes, resuspended in 4 packed cell volumes of
hypotonic lysis buffer (5 mM HEPES [pH 7.9], 25 mM KCl, 2 mM MgCh, 4%
glycerol, 20 mM DTT, 0.1 mM PMSF, 0.2 mM EDTA, 1% [v/v] NP-40), kept on
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ice for 20 minutes, lysed by douncing with 30 strokes in a tight-fitting Dounce
homogenizer, and nuclei were removed by centrifugation at 700 X g for 10
minutes. The protein in clarified lysate was quantitated with the Bradford kit
from BioRad and lysate was divided into 10 ul aliquots containing 20 ug total
protein each and stored at -80° C until use.
To synthesize positive-strand radiolabeled RNA probes for EMSAs and
crosslinking studies, pSLIII(PB) and mutant constructs pSLIII-mut2L(PB),
pSLIII-mut2R(PB), pSLIII-mut2L/R(PB), pSLIIl-mut4L/R(PB), pSLIIImutGU (PB), pSLIII-mutCA(PB), and pSLIII-mut3R(PB) were linearized with
restriction endonuclease Avr II and transcribed using T7 RNA polymerase in a 50
ul reaction volume containing 120 uCi of a-32P-UTP (300 Ci/mmol). For
synthesis of negative-strand radiolabeled RNA probes, the same radiolabeling
procedure was used except that pSLIII-minus(PB) and mutant constructs pSLIII
mutGUminus(PB) and pSLIII-mutCAminus(PB) were linearized with restriction
endonuclease EcoR V and transcribed with SP6 RNA polymerase. Radiolabeled
transcripts were purified by electrophoresis on an 8 M urea 6% polyacrylamide
gel (Andino et al., 1990) and recovered by elution (Thomson et al., 1999).
Unlabeled transcripts used as competitor RNA were chromatographed through a
Biospin 6 column (BioRad).
For EMSA, 1Xl 04 cpm of 32 P-UTP-labeled probe, and unlabeled
competitor RNAs when used, were incubated in renaturation buffer (20 mM
HEPES [pH 7.9], 60 mM KCl, 2 mM MgC}i) for 30 minutes at 45 ° C prior to
addition to a binding reaction mixture. For the binding reaction, the cell lysate (in
10 ul) was preincubated for 10 min at 30°C after the addition of 1 ul tRNA at 10
ug/ul, 1 ul PMSF at I 00 mM, and 1 ul heparin at I ug/ul. After addition of the
radiolabeled probe in approximately I ul, the mixture was incubated at 30° C for
I O min at which time 2 ul of 50% glycerol was added and the products were
electrophoretically separated on a 6% native polyacrylamide/5% glycerol gel at 4°
C in 0.5 X TBE ( 1 X TBE = 0.9 M Tris [pH 8.0], 0.09 M boric acid, 0.002M
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EDT A) electrophoresis buffer. In the competition assays, 5, 1 0, or 1 5 ug of
unlabeled probe RNA, or 5, 1 0, or 1 5 ug unlabeled yeast tRNA were used.
For the supershift assays, 2 ul of antiserum (containing approximately 40
ug of protein total) was added to the reaction mixture in one set before and in
another set after completion of the RNA-protein binding reaction and the mixture
was incubated on ice for 30 minutes prior to electrophoretic separation (Andino et
al., 1 990; Gutierrez-Escolano et al., 2000). Rabbit polyclonal anti-N and

preimmune sera (Hogue et al., 1 984), rabbit polyclonal anti Poly (C)-binding
protein (PCBP)-2 and preimmune sera (Blyn et al., 1 997) (kind gifts from E.
Ehrenfeld, U. C. Irvine), and mouse polyclonal anti-La antiserum (obtained from
BD Biosciences) were used.
For UV cross-linking and molecular weight determinations the method of
Pestova et al was used (Pestova et al., 1 99 1 ). For this, RNA-protein binding
reaction mixtures were irradiated at 3 mwatts/cm2 on ice for 30 minutes in a
Stratalinker UV cross linker 1 800 (Stratagene) and the preparation was digested
with a mixture of 1 00 U of RNase T l , 2.5 U of RNase A and 1 U of RNase CV l
(Ambion) for 40 minutes at 37° C. Protein molecules radiolabeled by virtue of
the cross-linked probe fragments were electrophoretically separated by SDS
PAGE on a gel of 1 0% polyacrylamide. Gels were dried and analyzed with a
Packard Instantlmager Autoradiography System for quantitation and exposed to
Kodak XAR-5 film for 1 to 10 days at -80°C for imaging. Images were recorded
by digital scanning of the film.
Accession numbers. The GenBank accession number for BCoV-Mebus is
U00735 .

RESULTS
Integrity of stem III in both the positive and negative strands is required
for BCo V DI RNA replication. The rationale applied here for evaluating the
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functional importance of a higher-order RNA element in DI RNA replication has
been previously described (Chapter II). Briefly, an element was judged necessary
for replication if mutations in structure led to a loss of DI RNA accumulation at
24 and 48 h post transfection and an absence of mutant progeny molecules in VP l
RNA. In the case of disrupted helical elements, restoration of some level of DI
RNA accumulation and the presence of the double mutant in cells infected with
VPl following a compensatory restoration of helix structure were also criteria
used. Replicating DI RNA molecules with wt structure in VPl originating from
mutant constructs were judged to be the result of recombination between input DI
RNA and the 5' end of the helper virus genome (Chapter II).
Analysis of base pair covariations within stem- loop III among group 2
coronaviruses shows maintenance of stable higher-order structure in both the
positive (free energy range, - 1 1 .5 to - 5 . 1 kcal/mole) and negative (free energy
range, -9.3 to - 3 .0 kcal/mole) strands (Chapter II). The question of which strand
stem-loop III functions in replication was not answered by stem disruption
experiments described previously (Chapter II) since negative free energy values
were maintained in both the positive and negative strands in all replicating
mutants, and higher-order structures were simultaneously disrupted in both
strands in the non-replicating mutants. Therefore, to test the strand requirements
in stem-loop III for DI RNA replication, mutations were made in pDrep 1 such
that higher-order structure was selectively destabilized in either the negative
(mutGU) or positive (mutCA) strand on the basis of m-fold predictions
(http://bioinfo.math.rpi.edu/~zukerm/; Mathews et al., 1 999; Zuker et al., 1 999)
and transcripts were tested for replication (Table 3 . 1 ; Fig. 3 . 1 ). For mutGU,
Northern analysis showed 1 7 % of wt levels at 24 hpt, 20 % at 48 hpt, and 1 5 % at
48 hpi in VP 1 RNA, and sequence analysis of the asymmetrically-amplified
cDNAs from VP l RNA showed all progeny to be wild type indicating transcripts
of mutGU had not replicated (Fig. 3 . 1 ). For mutant mutCA, Northern analysis
showed an accumulation of 1 5 % of wt levels at 24 hpt, 2 1 % at 48 hpt and 8 % in
VP l RNA, and sequence analysis showed all progeny from VP l to be wt
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Fig. 3.1. Integrity of stem III in both the positive and negative strands is
required for DI RNA replication in helper virus-infected cells, as
determined by analysis of mutant variants of pDrep1. The mfold
predicted structures of wt (pDrep l ) and mutants (pSLIII-mutGU and
pSLIII-mutCA) transcripts in the positive and negative strands and their
calculated free energies in kcal/mole are shown. Mutated bases are
shown as lowercase letters. The start codon for the intra-5' UTR ORF is
boxed. Accumulation was measured by Northern analysis with a
reporter-specific radiolabeled oligonucleotide. For Northern analyses,
T7 RNA polymerase-generated transcripts of linearized plasmids were
transfected into BCoV-infected cells and RNA was extracted at the
indicated times post transfection and at 48 h post infection with virus
passage 1 (VP1). Accumulation of pDrep1 progeny was considered to be
100%. The sequence of the RNA in VP1 progeny replicons was
determined by bulk RT-PCR sequencing using pDrep I -specific primers
as described in the text. Lanes: Uninf., mock infected, non-transfected
cells; Inf., infected, non-transfected cells; RNA, sample of the transcript.
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indicating this mutant also had not replicated (Fig. 3 . 1 ). Although the amino acid
sequence encoded by the stem-loop III-associated short ORF in both mutants was
not wt (Fig. 3 . 1 ), it is not likely that these differences would have blocked
replication since amino acid differences from wt were shown to be tolerated in
our earlier studies (Chapter II). Taken together these results indicate that the
integrity of stem-loop III in both the positive and negative strands is required for
DI RNA replication.
Viral or virally induced or modified cellular proteins of approximately 55
and 22 kDa molecular weight bind specifically to stem-loop III in the positive
strand. To test the hypothesis that stem-loop III functions in the positive strand
through interactions with cellular or viral proteins, EMSAs were done with
radiolabeled 1 20-nt transcripts in which the 20-nt wt stem-loop III was flanked
upstream by 34 and downstream by 66 nts (Fig. 3 .2). Two isoforms of the free
probe were produced, a not uncommon phenomenon (Black et al., 1 998), t�at
may reflect alternate folding of the probe molecule. On incubation with lysate
from uninfected cells one band of shifted probe identified as complex I was
evident (Fig. 3.2, lane 4 vs lane 1 ) whereas from BCoV-infected cells (lane 3) a
second shifted band identified as complex II was also evident. Elimination of
probe shifting by proteinase K treatment (lane 2) identified the binding molecule
as protein. These results suggest that1complex I was formed by probe interactions
with a cellular protein(s) and complex II with cellular and viral protein(s),
although in the second instance interactions with virally-induced or virally
modified cellular proteins was also a possibility. The likelihood that complex II
resulted from the products of virus-induced transcription of cellular genes,
however, seems unlikely since BCoV infection induces a potent 24 h transient
inhibition of host transcription as measured by pulse-chase labeling experiments
in HRT cells (unpublished data). The interaction in both complexes was specific,
furthermore, since addition of increasing amounts of unlabeled probe as
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Fig. 3 .2. Both cellular and viral proteins bind specifically to
positive strand stem-loop III-containing RNA. A uniformly
labeled 1 20 nt stem-loop III-containing positive strand RNA
probe was used in electrophoretic mobility shift assays as
indicated. Two isoforms of the probe were present. Probe
treatments: Lane 1 , incubated with buffer; lane 2, incubated with
proteinase K-treated infected cell lysate; lane 3, incubated with
infected cell lysate; lane 4, incubated with uninfected cell lysate;
lanes 5-7, incubated with infected cell lysate to which had been
added 5, 1 0, and 1 5 ug of unlabeled probe RNA, respectively;
lanes 8- 1 0, incubated with infected cell lysate to which had been
added 5, 1 0, and 1 5 ug yeast tRNA, respectively.
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competitor reduced complex formation in a dose dependent manner (Fig. 3.2,
lanes 5 to 7) whereas addition of tRNA, a presumed nonspecific competitor, did
not (lanes 8 to 1 0). These results together suggest that the positive-strand of
stem-loop III is able to complex with both cellular and viral or virally induced or
modified cellular proteins.
To determine whether the proteins are binding the 20-nt stem- loop III
element, and, simultaneously, to establish whether binding is specific to its
higher-order structure, EMSAs were done in a way that compared wt stem-loop
III to its mutant forms (Chapter 11; summarized in Table 3 . 1 ) (Fig. 3 .3). Probes
from all three mutants with a predicted higher-order structure, namely mut2L/R
(Chapter II, Fig. 2.3), mut4L/R (Chapter II, Fig. 2.5 B) and mutGU (Fig. 3 . 1 ),
were shifted to form complex I with lysates from uninfected cells (Fig. 3 .3 A, lane
5 and Fig. 3.3 B, lanes 5 and 9) and complexes I and II with lysates from infected
cells (Fig. 3.3 A, lane 6 and Fig. 3 .3 B, lanes 6 and 10) as did probe from wt (Fig.
3.3 A, lanes 3 and 4, and Fig. 3.3 B, lanes 3 and 4). Probes from mut2L (Chapter
II, Fig. 2.3) and mutCA (Fig. 3 . 1 ), on the other hand, with no predicted higher
order structure were shifted to form only a poorly defined complex I with both
uninfected and infected cell lysates (Fig. 3.3 A lanes 8- 10, and 3.3 B, lanes 1 1 1 3). Puzzlingly, probe from mut2R (Chapter II, Fig. 2.3) with a predicted
disrupted stem-loop III structure formed a diffuse pattern of shifted probe that
extended to the top of the gel (Fig. 3.3 A, lanes 1 1 and 1 2). These results showed
(with the exception of mut2R) there was a positive correlation between predicted
wt-like higher-order structure in stem-loop III in the positive strand and the
formation of a second RNA-protein complex (complex II).
To determine the number and sizes of proteins in the complexes, UV
cross-linking between the radiolabeled RNA and proteins was done followed by
RNase digestion and SDS PAGE (Fig. 3.4). By these analyses, three faintly
appearing cellular protein species of approximately 6 1 , 48, and 36 kDa, and
probably three more cellular proteins of approximately 45, 42, and 33 kDa in size
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Fig. 3.3. Viral proteins bind specifically to stem-loop III RNA in a
higher-order structure dependent manner (except for construct
mut2R). Electrophoretic mobility shift assays were done with
radiolabeled transcripts made from the indicated wt and mutant
constructs. All probes were 120 nts in length. In all cases two
isoforms of the probe were present. Mutant names used in the figure
are abbreviations.
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Fig. 3 .4. Viral proteins of approximately 55 and 22 kDa molecular
weight bind specifically to stem-loop III in the positive-strand. UV cross
linking was done on protein binding reactions prepared as described in
Fig. 3 .2. Reaction products were then digested simultaneously with
RNases T l , A and CV l , as described in the text and electrophoretically
separated on 1 0% SDS-PAGE gels. Numbers to the right indicate
molecular weight positions as determined by molecular weight markers,
and to the left indicate estimated molecular weights of the radiolabeled
proteins. Cellular proteins are indicated by filled rectangles and viral
proteins are indicated by filled arrowheads. B. 1 5 ug of yeast tRNA
(lane 1), and 1 5 ug of wild type unlabeled probe RNA (lane 7) were
incubated with the cell lysate prior to the addition of the radio labeled
probe.
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were observed with various degrees of resolution with lysates from uninfected
cells with wt probe (identified as filled rectangles in Fig. 3 .4 A, lane 9, Fig. 3 .4 B,
lane 3 and Fig. 3 .4 C, lane 2). Increasing the RNase concentration three-fold did
not improve the resolution of the bands indicating poor resolution was probably
not caused by incomplete digestion of large cross-linked RNA tags. From
infected cells, proteins of approximately 55 and 22 kDa and probably a 38 kDa
protein were additionally observed with wt probe (identified as filled arrowheads
in Fig. 3 .4 A, lane 8, Fig. 3.4 B, lanes 1 and 2, and Fig. 3.4 C, lane 1 ). Curiously,
the abundance of some of the binding cellular proteins from lysates of infected
cells appeared increased over uninfected cells. The elimination of bands with
proteinase K (Fig. 3 .4 B, lane 4) confirmed their protein identity. Additionally,
all proteins bound specifically to the stem-loop III probe since addition of 1 500fold excess unlabeled transcript (Fig. 3.4 B, lane 7) but not tRNA (Fig. 3 .4 B, lane
1 ) prevented crosslinking.
In a pattern that reflected their results from EMSAs, probes from mutants
that retained stem-loop III-like higher-order structure, namely, mut2L/R (Fig. 3.4
A, lane 1 ), mut4L/R (Fig. 3 .4 C, lane 5), and mutGU (Fig. 3.4 B, lane 1 0), were
bound by the six cellular protein species to varying degrees, and also by the 5 5
and 22 kDa viral proteins (Fig. 3.4A, lane 2, Fig. 3.4 C, lane 4, and Fig. 3 .4 B,
lane 9, respectively). Probe from mutants lacking a predicted higher-order
structure, on the other hand, namely mut2L and mutCA (Chapter 11; Table 3. 1 ;
Fig 3 . 1 ), bound only the cellular proteins from both uninfected and infected cells
(Fig. 3 .4 A, lanes 3 and 4, and Fig. 3 .4 B, lanes 6 and 8). As with the EMSA
results, the exception to this correlation was mut2R (Fig. 3 .4 A, lane 6) in which
the stem-loop III structure was predicted to be disrupted but which bound the 55
and 22 kDa viral proteins. Curiously, mutant mut2R showed a pattern of protein
binding that was different from any of the other constructs, and the amounts of
cellular protein bound, at least for all but the 6 1 kDa species (Fig. 3.4 A, lane 5),
were inexplicably greater. These results, with the exception of mut2R, again
show the binding of viral proteins to be a function of the higher-order structure of
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stem-loop III. Further, the observation that protein binding to construct mut4L/R,
in which the stem-loop III associated AUG codon was disrupted, was
indistinguishable from that with wt stem-loop III (Fig. 3.4 C) indicated that the 5'
UTR ORF pre se was not important for protein binding.
Since the nonreplicating mut2R with a predicted stem-loop III-disrupted
structure (Chapter II; Table 3. 1 ) was also bound by the putative 55 and 22 kDa
viral proteins as noted (Fig. 3 .4 A, lane 6), it was postulated that there may exist
an alternate higher-order structure that would function as binding sites for the
viral proteins but would not necessarily as a result of that binding fulfill a
replication function. To examine this possibility, the predicted folding of mut2R
was re-examined with the mfold program of Zuker (Mathews et al., 1 999; Zuker

et al., 1 999). Whereas the wt stem III was disrupted in mut2R (Chapter II), a
highly likely alternate stem-loop was found that mapped between nts 1 00 through
142 (Fig. 3.5 B). To test that it is possibly this alternate structure that is
recognized by the viral proteins, mut3 R (Fig. 3 .5 C) was made in which it was
predicted that no higher-order structure resembling that of wt or mut2R would be
retained and protein binding was examined (Fig. 3 .5 A, lanes 7 and 8). Whereas
mut3R RNA showed the same pattern of cellular protein binding as did mut2R
(Fig. 3.5, lane 8), it did not show binding by the 55 kDa viral protein (Fig. 3.5,
lane 7). Proteins near the size of the 22 kDa protein were not resolved in this
study so a conclusion about the binding of the 22 kDa viral protein could not be
made. The elimination of bands with proteinase K (Fig. 3.5 A, lane 1 ) confirmed
their protein identity. Additionally, all proteins bound specifically to the mut2R
probe since addition of 1500-fold excess unlabeled mut2R transcript (Fig. 3.5 A,
lane 3) but not tRNA (Fig. 3 .5 A, lane 2) prevented crosslinking.
The positive correlation between viral protein binding to a higher-order
wt-like structure of stem-loop III in the positive strand and replication would
suggest viral protein binding in a higher-order-dependent manner is a mechanistic
feature of stem-loop III function in RNA replication. The surprising finding that
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Fig. 3.5. Positive-strand transcripts of mut2R form an alternate higher
order structure that binds the 5 5 kDa viral protein. UV cross-linking,
RNase digestion and SDS-PAGE gel electrophoresis were done as
described in Fig. 3 .4. Numbers to the right indicate molecular weight
positions as determined by molecular weight markers, and to the left
indicate estimated molecular weights of the radiolabeled proteins. Cellular
proteins are indicated by filled rectangles and viral proteins by filled
arrowheads. The mfold-predicted structures of the mut2R alternate stem
loop (part B), and mut3R (part C) and their calculated free energies in
kcal/mole are shown. Mutated bases are shown as lowercase letters. The
start codon for the intra-5 ' UTR ORF is boxed. A. 1 5 ug of yeast tRNA
(lane 2), and 1 5 ug of mut2R unlabeled probe RNA (lane 3) were incubated
with the cell lysate prior to the addition of the radio labeled probe.
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the non-replicating mut2R forms a predicted alternate higher-order structure that
also binds viral proteins makes this conclusion less straightforward, but it is
possible that the orientation of the bound viral proteins on the alternate stem- loop
is stoichiometrically inappropriate to fulfill a replication function.
The 55 kDa viral protein binding to stem-loop III in the positive strand is
the nucleocapsid (N) protein. Of the predicted fully-processed protein products of
the BCoV genome ( 1 8 nonstructural and 8 structural proteins), the abundant 50
kDa [52 kDa reported molecular weight by SDS-PAGE (Laude et al., 1 995)] N
protein is the most likely candidate for the bound 55 kDa mol. wt. viral protein.
To test the hypothesis that it is, an electrophoretic mobility supershift assay was
done on the RNA protein complex II with antiserum to BCoV N protein. A
supershift of complex II to form a complex III with N immune (Fig. 3 .6, lanes 9
and 1 0) but not N preimmune (Fig. 3 .6, lane 4) serum indicated this is the case.
Probe incubated with proteinase K-treated lysate from infected cells to which
either N immune (lane 3), or N preimmune (lane 1 1) had been added showed no
shifting thus confirming the protein nature of the supershifting molecules. Taken
together these data indicate that the 55 kDa binding protein from virus-infected
cells is the viral N protein and suggest that stem-loop III might function as a cis
acting element through its interactions, at least in part, with the N protein.
Since the 47 kDa La protein and the 39 kDa poly(C)-binding protein 2
(PCBP-2) are cellular proteins known to bind a number of viral RNA elements
(Gamarnik et al., 1 998; Parsley et al., 1 997; Yocupicio-Monroy et al., 2003 ; and
references therein), the hypothe�is was tested by supershift assays with uninfected
cell lysates that these were binding the positive-strand stem-loop III RNA.
Supershifting of wt probe complex I with uninfected cell lysates was not observed
with either antiserum to La (Fig. 3.6, lanes 6 and 7) or to PCBP-2 (data not
shown) indicating that La and PCBP -2 are not among the cellular proteins binding
the stem-loop III element in the positive strand.
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Fig. 3.6. The 5 5 kDa viral protein binding to positive-strand stem-loop III is
the N protein. The electrophoretic mobility supershift assay was done using
either N or La antiserum as indicated in the figure. A 1 20 nt stem-loop III
containing probe as described in Fig. 3.2 was used. Probe treatments: Lane 1 ,
incubated with buffer; lane 2, incubated with proteinase K-treated infected cell
lysate to which La antiserum was added; lane 3, incubated with proteinase K
treated infected cell lysate to which N antiserum was added; lane 4, incubated
with infected cell lysate to which N preimmune serum was added; lane 5,
incubated with uninfected cell lysate; lanes 6 and 7, incubated with uninfected
cell lysate to which La antiserum was added either before (lane 6) or after
(lane 7) the RNA-protein binding step; lane 8, incubated with infected cell
lysate; lanes 9 and 1 0, incubated with infected cell lysate to which N
antiserum was added either before (lane 9) or after (lane 1 0) the RNA-protein
binding step; lane 1 1 , incubated with proteinase K-treated infected cell lysate
to which N preimmune serum was added.
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Seven cellular proteins but no viral proteins bind specifically to the
negative-strand form of stem-loop III. Since the integrity of stem-loop III in the
negative as well as positive strand was necessary for BCo V DI RNA replication
(Fig. 3 .1 ), the hypothesis was tested by EMS As that it in the negative strand
interacts with cellular or viral proteins as a possible mechanism of action. For
this, pSLIII-minus(PB) was used with SP6 RNA polymerase to generate
uniformly radiolabeled 1 30-nt probes of wt minus-strand stem-loop III RNA in
which the 20-nt stem-loop was flanked upstream by 79 nts and downstream by 3 1
nts. As with the positive-strand probes, two isoforms of the free probe were
observed for wt and all mutants. With lysates of uninfected (Fig. 3.7, lane 4) or
1

infected (Fig. 3.7, lane 3) cells, wt probe formed two shifted bands of lower
mobility identified as complexes I and I'. It is presumed that the two bands
represent complexes with cellular proteins of different composition but it could
alternatively reflect the behavior of the two isoforms of the probe. Elimination of
probe shifting by proteinase K treatment (Fig. 3.7, lane 2) confirmed the protein
nature of the probe-shifting molecule. The complexes, furthermore, were specific
to stem-loop III-containing negative strand RNA since addition of increasing
amounts of unlabeled probe as competitor reduced complex formation in a dose
dependent manner (Fig. 3.7, lanes 5 to 7) whereas addition of tRNA did not (lanes
8 to 1 0). These results indicate that stem-loop III-containing negative-strand
RNA was bound specifically by cellular but not by viral proteins to form two
RNA-protein complexes.
To determine whether the proteins are binding to the 20-nt negative-strand
stem-loop III element and to establish whether the binding is specific to its
higher-order structure, EMSAs were done that compared wt to mutGUminus
which does not retain higher-order structure and mutCAminus which does (Table
3 . 1 ; Fig. 3.1). Interestingly, probes from mutGUminus were not bound by either
cellular or viral proteins (Fig. 3.8, lanes 5 and 6) whereas probes from wt (Fig.
3 .8, lanes 3 and 4) and mutCAminus (Fig. 3.8, lanes 9 and 1 0) were bound only
by cellular proteins to form the two RNA-protein complexes identified as I and I'.
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Fig. 3.7. Cellular proteins bind specifically to negative-strand
stem-loop III-containing RNA. A uniformly labeled 130 nt
stem-loop III-containing negative strand RNA probe was used
in electrophoretic mobility shift assays and probe treatments
were as described in Fig. 3.2. Two isoforms of the probe were
present.
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Fig. 3.8. Cellular proteins bind specifically to negative-strand stem
loop III in a higher-order structure dependent manner.
Electrophoretic mobility shift assays were done with radiolabeled
transcripts made from the indicated wt and mutant constructs. All
probes were 130 nts in length. In all cases two isoforms of the
probe were present. Mutant names used in the figure are
abbreviations.
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These results indicate that cellular proteins bind the negative-strand form of stem
loop III in a higher-order structure dependent manner.
To determine the number and sizes of proteins in the complexes, UV
cross-linking analyses were carried out. Protein patterns were found to be
indistinguishable between uninfected and infected cells and showed binding by
seven proteins with approximate molecular weights of 76, 66, 48, 45, 4 1 , 33 and
25 kDa (Fig. 3. 9, lanes 5 and 6). These results were consistent with the identical
EMSA patterns from uninfected and infected cell lysates (Fig. 3 .8, lanes 3 and 4)
indicating that cellular but not viral proteins were binding to the minus-strand of
stem-loop III. Elimination of all seven bands by proteinase K treatment (Fig. 3.9,
lane 4) confirmed their protein identities. All seven proteins bound specifically
since the addition of 1 500-fold excess of unlabeled transcript prevented complex
formation (Fig. 3.9, lane 7) whereas the same amount of yeast tRNA did not (lane
2). Furthermore, the binding of all seven proteins to minus strand was found with
the mutations that maintained the higher-order structure (mutCAminus, Fig. 3.9,
lane 1 ) but not with those mutations that disrupted it (mutGUminus, Fig. 3.9, lane
3).
Taken together, these data suggest that the seven proteins with molecular
weights of 76, 66, 48, 45, 4 1 , 33 and 25 kDa interact specifically with the higher
order structure of stem-loop III in the negative strand and that this interaction may
reflect a mechanistic feature of stem-loop III.

DISCUSSION
Previous studies on stem-loop III had shown it to function as a cis-acting
element in BCoV DI RNA replication and that maintenance of an intra-5' UTR
ORF of 24 nt was strongly preferred but not absolutely required for DI RNA
replication (Chapter II; Raman et al., 2003). Here, we show by mutational
analyses in DI RNA that stem-loop III, as a higher-order structure, functions in
replication in both the positive and negative strands. Protein binding studies
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Fig. 3.4. Numbers to the right indicate molecular weight positions
as determined by molecular weight markers, and to the left
indicate estimated molecular weights of the radiolabeled proteins.
1 5 ug of yeast tRNA (lane 2), and 1 5 ug of wild type unlabeled
probe RNA (lane 7) were incubated with the cell lysate prior to the
addition of the radio labeled probe.

70

demonstrate that viral proteins of approximately 55 and 22 kDa mol. wt. bind to
wt and mutant forms of stem-loop III in which stem-loop III structure is
maintained (except in one case), in the positive strand in a higher-order-dependent
manner. The 5 5 kDa protein, furthermore, was shown to be the viral N protein in
an antibody-dependent electrophoretic mobility supershift assay. Cellular
proteins of 6 1 , 48, 45, 42, 36, and 33 kDa mol. wt. also bound to the positive
strand probes but in a higher-order-independent manner. In the negative strand,
seven cellular proteins of approximately 76, 66, 48, 45, 4 1 , 33 and 25 kDa mol.
wt. bound in a higher-order-dependent manner suggesting that this binding too
may be part of the mechanism of action of stem-loop III.
With the exception of viral N, the identity of the binding viral and cellular
proteins is unknown, nor is it known whether the species identified represent
wholly intact molecules or disassembled components of larger proteins. Certainly
disulfide-linked multimeric polypeptides have been separated by the reducing
conditions of the SOS-PAGE. It is quite possible that the 55 kDa cellular protein
found earlier to bind positive-strand RNA in a region that includes stem-loop III
in the MHV-JHM genome, and the 3 8 and 3 5 kDa proteins found to bind the
complement of this region (Furuya et al., 1 993), are among the cellular proteins
identified here. We conclude from our study, however, the 39 kDa poly(C)
binding protein 2 and the 47 kDa La cellular protein are not among those that bind
either the positive, or the negative (data not shown) strand of stem-loop III.
How does stem-loop III in BCoV DI RNA function mechanistically in
replication? The most straight-forward and simplest answer might be that it
functions as a packaging signal for the DI RNA. We use as one criterion of
replication, after-all, the presence of the higher-order mutant DI RNA in cells that
had been delivered by infectious virus (i.e., VPl ). Although we cannot rigorously
rule out the packaging explanation, we think it unlikely since we also use as
criteria the measurement of how abundantly the mutated DI RNAs accumulate
prior to packaging, and in no case did we see abundant accumulation with
accompanying absence in VPl RNA.
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Since previous studies using BCoV DI RNA had indicated ORF (open
reading frame) 1 a is translated by ribosomal scanning from the 5' end of the
genome (Senanayake et al., 1 999), we propose that secondary structures in the 5'
UTR do not function as part of an internal ribosomal entry site (IRES) but rather
as structures enabling RNA synthesis. Conceivably, this might happen by stem
loop III, probably along with stem-loop IV (Chapter IV), forming a structure
around which an RNA replication complex would form. Since the integrity of
stem III is required in both the positive and negative RNA strands for DI RNA
replication (Fig. 3.1 ), we further propose that stem-loop III is important in two
steps required for RNA replication, first in the initiation of negative-strand
synthesis and second in the initiation of positive-strand synthesis. With regard to
the initiation of negative-strand synthesis, we envision that stem-loop III (together
with stem-loop IV) in the positive strand functions as a cis-acting element for the
initiation of negative-strand synthesis through a mechanism that involves physical
interaction of the 5' and 3' ends of the DI RNA. This aspect of the mechanism is
no different from that proposed for other plus-strand RNA viruses wherein
physical interactions between the genomic 5' and 3' ends leading to cyclization of
the genome have been documented. In the case of bacteriophage Q beta (Klovins
et al., 1 998; Klovins et al., 1 999) and the an�mal flaviviruses (Khromykh et al.,
200 1 ; Corver et al., 2003; You et al., 1 999; You et al., 200 1 ) the cyclization
results from direct interaction of RNA elements. In the case of picomaviruses
(Barton et al., 2001 ; Herold et al., 2001 ) and alphaviruses (Frolov et al., 200 1 ), it
is one mediated by protein bridges.
The model for coronavirus RNA replication as we propose it (Fig. 3.1 0)
has the following features: (i) It explains how genome usage for viral translation,
viral negative-strand RNA synthesis and viral positive-strand RNA synthesis is
coordinated. (ii) The initial viral translation step of the 5' most ORF that codes for
the viral polymerase and a variety of peptides is proposed to be initiated by the
circularization of the capped and polyadenylated viral genome through the 7mG
eIF 4E (eukaryotic initiation factor 4E) - eIF4G (eukaryotic initiation factor 4G)-
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Fig. 3.10. Model for coronavirus RNA replication. A. The circular RNP
complex for initiation of translation is proposed to be made up of the 5' cap,
eIF4E, eIF4G, poly[A] binding protein (PABP), poly[A] tail interaction. B. The
interaction of the 5' and 3 ' ends of the positive-strand genome to form a circular
RNP complex that is proposed to be required for initiation of negative-strand
synthesis is mediated by a protein bridge formed by the N protein and the 22 kDa
viral protein (V.P) interacting with stem-loop III, the cellular proteins (C.Ps) that
interact specifically with stem-loop IV, the PABP, and probably proteins
interacting with the 3 ' end of the genome. This circular RNP complex probably
forms a structure around which the replication complex forms. It probably also
positions the RdRp at the 3 ' end of the genome for negative-strand initiation. C.
The cellular proteins interacting with stem-loop III in the negative-strand
probably form part of the replication complex for initiation of positive-strand
synthesis by interacting either directly or indirectly with the RdRp. Stem-loops I
(nts 5 to 37), II (nts 51 to 84) (Chang et al., 1994), III (nts 97 to 116) (Chapter II),
and IV (Chapter IV) in the 5' UTR, and the bulged stem-loop (Hsue et al., 1997)
and pseudoknot (Williams et al. , 1999) in the 3' UTR are shown. The arrow
indicates the direction in which RNA synthesis takes place.
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PABP (poly[A] binding protein)- poly[A] tail interaction (Fig. 3.10 A). This
method of cyclization has been thought to be a key structural requirement for the
initiation of translation of most eukaryotic cellular mRNAs (Gallie, 1998; Gallie,
2002; lmataka et al., 1998; Wells et al. , 1998). (iii) Viral negative-strand RNA
synthesis is proposed to be initiated by a circularization mechanism in which the
interaction of the 5' and 3' ends of the genome is mediated by a protein bridge
comprised of the 50 kDa N protein and the 22 kDa viral or virally induced or
modified cellular protein binding to stem-loop III, the eight cellular proteins
binding specifically to stem-loop IV (Chapter IV), the poly[A] binding protein
(PABP) binding to the poly[A] tail (Spagnolo et al., 2000), and possibly the N
protein binding to the leader region (Nelson et al., 2000; Stohlman et al., 1988),
and other proteins that bind to the 3' end of the genome (Fig. 3.10 B). This
circular ribonucleoprotein (RNP) complex probably acts as a nucleation site for
formation of the replication complex that includes the RNA-dependent RNA
polymerase (RdRp) and the helicase. The circular RNP complex may also help in
proper positioning of the RdRp and helicase at the 3' end of the genome where
initiation of negative-strand synthesis takes place. In addition to forming a part of
the circular RNP complex, the N protein might directly interact with the helicase,
an interaction that was proposed based on co-immunoprecipitation assays
(Denison et al., 1999). Since viral negative-strand RNA synthesis begins before
the N protein is synthesized from its subgenomic mRNA, we propose that
probably sufficient N protein is present in the infecting virion for formation of the
negative-strand initiation complex. On the other hand, when naked coronavirus
genome is used for infection, a situation in which N is not present, what would be
the source of N? In order for the presence of N protein to precede the initiation of
negative-strand synthesis it would have to be synthesized by translation of the N
ORF of the virus genome by internal entry of ribosomes, a mechanism that is
proposed to occur (Senanayake and Brian, unpublished). (iv) For initiation of
viral positive-strand RNA synthesis, the RdRp is proposed to be correctly
positioned at the 3' end of the negative-strand viral RNA through its interactions
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either directly or indirectly with the seven cellular proteins that interact with stem
loop III in the negative strand (Fig. 3.1 0 C). (v) Thus we propose that employing
of different mechanisms for initiation of translation, negative-strand synthesis,
and positive-strand synthesis regulates the usage of the viral genome.
Further studies directed toward testing of this model, and also
identification of the 22 kDa viral or virally induced or modified cellular protein
binding to positive-strand stem-loop III and the seven proteins binding to
negative-strand stem-loop III in a higher-order-dependent manner should provide
insight into how the various RNA and protein elements, including stem-loop III
function in DI RNA replication.
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CHAPTER IV. STEM-LOOP IV IN THE 5' UNTRANSLATED
REGION IS A CIS-ACTING ELEMENT IN BOVINE
CORONAVIRUS DI RNA REPLICATION.
INTRODUCTION
Higher-order RNA structural elements in the 5' and 3' untranslated
regions of positive-strand RNA virus genomes are known in many cases to
function as cis-acting elements in genome translation, replication and
transcription. The characterized mechanistic involvement of these structures in
the 5' UTR has included (i) regulation of translation responsible for both
downstream cis- and trans-acting factors in replication (Bink et al. , 2003; Blyn et
al. , 1 997; Fletcher et al. , 2002; Pestova et al. , 1 99 1 ; Yu et al. , 2000; and

references therein), (ii) the binding of viral or cellular proteins to carry out
necessary replication functions, including circularization of the virus genome
(Andino et al. , 1 990; Barton et al. , 2001 ; Frolov et al. , 200 1 ; Gamarnik et al. ,
1 997; Gamarnik et al. , 1 998; Herold et al. , 200 1 ; Sizova et al. , 1 998), (iii) a direct
interaction with other RNA structural elements, including 3'-terminal structures,
to fulfill requirements for replication (Corver et al. , 2003; Khromykh et al. , 200 1 ;
Klovins et al. , 1 998; Klovins et al. , 1 999; You et al. , 1999; You et al. , 200 1 ), and
(iv) promoter function on the (complementary) negative-strand RNA for initiation
of plus-strand synthesis (Yu et al. , 2000). The mechanistic features of many
higher-order 5' UTR cis-acting elements remain to be characterized.
In BCoV, four RNA stem-loops mapping mostly within the 21 0-nt 5'UTR
have been predicted and, of these, stem-loops I and II have been shown to lie in a
region of the 5' UTR (nts 1 -84) required for DI RNA replication but do not appear
to have higher-order counterparts in other coronavirus genomes (Chang et al. ,
1 994 ). Stem-loop III shows phylogenetic conservation and a cis-acting function
in DI RNA replication (Chapter II; Raman et al. , 2003). Experimental evidence
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indicates both viral and cellular protein binding may play a role in the function of
stem-loop III (Chapter III).
Here, we characterize the higher-order structure, analyze the potential
phylogenetic conservation, and test for the function in DI RNA replication of a
predicted stem-loop IV. In addition, we investigate by electrophoretic mobility
shift and UV cross-linking assays the potential binding of viral and cellular
proteins to stem-loop IV.

MATERIALS AND METHODS
Virus and Cells. A DI RNA-free stock of the Mebus strain of BCoV at 4.5
8

X 1 0 PFU/ml was prepared and used as a helper virus as previously described
(Chang et al. , 1 994; Raman et al. , 2003). The human rectal tumor cell line HRT1 8 (Tompkins et al. , 1 974) was used as previously described (Chang et al. , 1 994;
Raman et al. , 2003).
Plasmid constructs. Construction of pGEM3Zf(-) (Promega)-based pDrep
1 has been previously described (Chang et al. , 1 994). To construct the plasmid
derivatives of pDrep 1 used in this study (Table 4. 1 ), overlap PCR mutagenesis
(Horton et al. , 1 990) was done using the oligonucleotides listed in Table 4.2. The
strategy for constructing each of the derivatives was the same as that used for
constructing pSLIV-mutR except for the differences noted. For making pSLIV
mutR, primers SR673(+), SRST6R2MUT(-), and pDrepl DNA were used in the
first PCR, primers SRST6R2MUT(+), Forward(-), and pDrepl DNA were used in
the second reaction, and primers Forward(-) and SR673(+) and the products of the
first two reactions were used in the third reaction to make a 71 0-nt product that
was trimmed to 442 nts with restriction endonucleases Hpa I and Xba I and
cloned into Hpa I/Xba I-linearized pDrepl. For making pSLIV-mutL,
SRST6MUT(-) replaced SRST6R2MUT(-) in the first reaction, and
SRST6MUT(+) replaced SRST6R2MUT(+) in the second reaction. For making
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Table 4. 1 . S

-....J
\0

f

looo- IV mutant

Mutant
name

Sequence in stem-loop IV mutant
(nts 186-2 15)

Property of stemloop IV mutant

kcal/
mole
in (+)
strand 8

Replikcal/
mole
cation b
in (-)
strand8

pSLIVPB(wt)
pSLIVmutdel
pSLIVmutL
pSLIVmutR
pSLIVmutL/R
pSLIVmutCA

-GGCAGUGGCCCACCCAUAGGUCACAAUGUC-

wt

-9.8

-6.7

yes

Number
of UVcrosslinked
protein
bands
11

-��������������������UCACAAUGUC-

no

3

Stern is disrupted.

no

3

-GGCAGacuggCACCCAUAccgguCAAUGUC-

Stem is re-formed.

-9.8

no
struct.
no
struct.
no
struct.
-6.7

3

-GGCAGUGGCCCACCCAUAccgguCAAUGUC-

no
struct.
no
struct.
no
struct.

no

-GGCAGacuggCACCCAUAGGUCACAAUGUC-

Stem-loop mostly
removed.
Stem is disrupted.

yes

11

-GGCAGcaGCCCACCCAUAGGUCACAAUGUC-

- 1 .0

-5. 1

no

3

pSLIVmutGU

-GGCAGUGGCCCACCCAUAGGUugCAAUGUC-

Stem-loop retained
in (-) but
destabilized in (+)
strand.
Stem-loop retained
in (+) but
destabilized in (-)
strand.

-6.7

- 1 .2

yes

11

Table 4. 1 . Continued.
Mutant
Sequence in stem-loop IV mutant
name
(nts 186-2 15)

pSLIV-GGCAGUGGCCCA�CCAUAGGUCACAAUGUCmutC198del
pSLIV-GGCAGUGGCCCACuuAUAGGUCACAAUGUCmut7

Property of
stem-loop IV
mutant

kcal/
mole
in (+)
strand8

Replikcal/
cation b
mole
in (-)
strand8

Number
of UVcrosslinked
protein
bands
11

yes
-9.8
-6.7
C3 in loop
deleted
3
no
-6.7
C4 and C5 in
-9.8
loop changed
to U's
a. In some cases, no structure was predicted by the Zuker algorithm and this is indicated.
b. Said to be replicating if there was accumulation at 24 and 48 h post transfection and the mutant form is present in cells infected
�
with VP1 following transfection.

Table 4.2. 01"
leotid
8
Polarity
Oli2onucleotide
Hpal (+)
+
Hpal (-)
Nde l (+)
+
GEM3Zf(-)Nde 1 (-)
+
Forward(-)
+
SRST6R2MUT(-)
SRST6R2MUT(+)
SRDM(+)
SR673(+)
+
SRST6MUT(-)
SRST6MUT(+)
+
SRST6DOUBLE(-)
SRST6DOUBLE(+)
+
SRleader(-)
Nonly(+)
SR25 1 (+)
SR280(+)
+
SR5 'UTR(-)
+
SRC 1 98(-)
SRC 1 98(+)
+
SRL6MUT(-)
SRL6MUT(+)
+
SRST4CA(-)
SRST4CA(+)
+
SRG208DEL(-)

d in Ch
IV
Sequence (5'->3'l
GGCTGAAAGCTGTTAACAGCAGAAATG
CATTTCTGCTGTTAACAGCTTTCAGCC
CCTCCAAATCATATGGACGTGTATTC
GAGAGTGCACCATATGCGGTGT
TAATACGACTCACTATA
GTGGCCCACCCATAccggtCAATGTCGAAGATC
GATCTTCGACATTGaccggTATGGGTGGGCCAC
GTTGATCTTCGACATTGTGACC
CAAGAATAGTAGGGTACAAC
GTATCCTAGGCAGactggCACCCATAGGTC
GACCTATGGGTGccagtCTGCCTAGGATAC
GactggCACCCATAccggtCAATGTCGAAGATC
GATCTTCGACTTGaccggTATGGGTGccagtC
GATTGTGAGCGATTTGCGTGCGTGC
CCAGAACGATTTCCAAAGGACGCTCT
CATCCATGGAAATTCTGGAG
CGTCCTCAAACATCCATGGAAATTCTGGAG
CATCCACTCCCTGTATTCTATGC
CCTAGGCAGTGGCCCACCATAGGTCACAATG
CATTGTGACCTATGGTGGGCCACTGCCTAGG
CCTAGGCAGTGGCCCACttATAGGTCACAATG
CATTGTGACCTATaaGTGGGCCACTGCCTAGG
CGTGTTGTATCCTAGGCAGcaGCCCACCCATAGGTC
GACCTATGGGTGGGCtgCTGCCTAGGATACAACACG
CGTGTTGTATCCTAGTCACAATGTCGAAGATC

Binding region in pDrepl
140- 1 66
140- 1 66
456-481
2498-25 1 9c
3 1 83-3200c
1 90-222
1 90-222
204-225
673-692
1 78-207
1 78-207
1 90-222
1 90-222
1 -25
532-557
25 1 -270
25 1 -280
8 1 - 1 03
1 82-2 1 3
1 82-2 1 3
1 82-2 1 3
1 82-2 1 3
1 72-207
1 72-207
1 72-222

Table 4.2. Continued.
Oligonucleotide8 Polarity Sequence (5'->3't

00

N

Binding
region in
pDrepl
SRST4GU(-)
+
GGCAGTGGCCCACCCATAGGTtgCAATGTCGAAGATCAACAAATACGGTC 1 86-23 5
SRST4GU(+)
GACCGTATTTGTTGATCTTCGACATTGcaACCTATGGGTGGGCCACTGCC
1 86-235 .
SRG208DEL(+)
GATCTTCGACATTGTGACTAGGATACAACACG
1 72-222
SRECOR5(-)
+
GTGAATTGTAATACGACTCACTATAGATatcGAGCGATTTGCGTGCGTGC
3 1 75 c-25
SRECOR5(+)
3 1 75 c -25
GCACGCACGCAAATCGCTCgmATCTATAGTGAGTCGTATTACAATTCAC
TGEV8(+)
CATGGCACCATCCTTGGCAACCCAGA
1 098- 1 1 23
TGEV8b(+)
CATGGCACCATCCTTGGCA
1 1 05-1 1 23
a. The positive and negative symbols in the oligonucleotide names indicate the polarity of the nucleic acid to which the
oligonucleotide anneals.
b. Lowercase bases represent mutated sites.
c. Indicates nucleotide positions in the pGEM3Zf(-) vector.

pSLIV-mutL/R, SRST6DOUBLE(-) replaced SRST6R2MUT(-) and pSLIV-mutL
DNA replaced pDrepl DNA in the first reaction, and SRST6DOUBLE(+)
replaced SRST6R2MUT(+) and pSLIV-mutL DNA replaced pDrep 1 DNA in the
second reaction. For making pSLIV-mutGU, SRST4GU(-) replaced
SRST6R2MUT(-) in the first reaction and SRST4GU(+) replaced
SRST6R2MUT(+) in the second reaction. For making pSLIV-mutCA,
SRST4CA(-) replaced SRST6R2MUT(-) in the first reaction, and SRST4CA(+)
replaced SRST6R2MUT(+) in the second reaction. For making pSLIVmutC 1 98del, SRC 1 98(-) replaced SRST6R2MUT(-) in the first reaction, and
SRC I 98(+) replaced SRST6R2MUT{+) in the second reaction. For making
pSLIV -mut7, SRL6MUT(-) replaced SRST6R2MUT(-) in the first reaction and
SRL6MUT(+) replaced SRST6R2MUT(+) in the second reaction. pSLIV-mutDel
was made in a two-step procedure as follows: (i) pSM3del was made by digesting
pSM3 (pDrep 1 with a G inserted at position 208 to create a Sal I restriction
enzyme site [Chang et al. , 1 996]) with Avr II (which cuts at nt 1 83) and Sal I
(which cuts at nt 205), filling in with Kienow enzyme and ligating (thus removing
the stem-loop IV-containing 1 86nt to 205nt fragment). (ii) 0208 was removed
from pSM3del by PCR mutagenesis to create pSLIV-mutDel. For this, the steps
as described above for synthesis of pSLIV -mutR were used except that
SRG208DEL( -) replaced SRST6R2MUT( -) and pSM3del DNA replaced pDrep 1
DNA in the first reaction, and SRG208DEL(+) replaced SRST6R2MUT(+) and
pSM3del DNA replaced pDrep 1 DNA in the second reaction.
For making pSLIV(PB), identical to pDrepl except nts 4 through 1 52 are
missing thus enabling synthesis of 1 1 3-nt stem-loop IV-containing probes for
testing protein binding, a two step procedure was used: (i) An EcoR V restriction
endonuclease site was created at nt 3 in pDrep 1 by overlap PCR mutagenesis in
which Nde l (+), SRECOR5(-) and pDrepl DNA were used in the first reaction,
SRECOR5(+) and GEM3Zf(- )Nde l (-) and pDrep l DNA were used in the second
reaction, and GEM3Zf(-)Nde l (- ) and Nde l (+) and the products of the first two
reactions were used in a third reaction to make a 1 1 83-nt product that was
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trimmed to 69J nts with restriction endonucleases NgoM IV and Avr II and
cloned into NgoM IV/Avr II-linearized pDrep l . (ii) The resulting plasmid was
digested with EcoR V and Hpa I to remove nts 4 through 152 and the ends of the
remaining fragment were ligated. The strategy used for making pSLIVmutDel(PB) was the same as that for making pSLIV(PB) except that (i) pSLIV
mutDel DNA was used instead of pDrep l DNA, (ii) the 1163-nt product from the
third PCR reaction was trimmed to 663 nts with restriction endonucleases NgoM
IV and Hpa I, and (iii) the product was cloned into NgoM IV/Hpa I-linearized
pSLIV -mutDel DNA.
For making pSLIV-mutR(PB), pSLIV-mutL(PB), pSLIV-mutL/R(PB),
pSLIV-mutC l 98del(PB), pSLIV-mut7(PB), pSLIV-mutGU(PB), and pSLIV
mutCA(PB), pSLIV(PB) was digested with NgoM IV and Avr II and the 545 nt
fragment was cloned into the respective NgoM IV/Avr II-linearized mutant
plasmids pSLIV-mutR, pSLIV-mutL, pSLIV -mutL/R, pSLIV-mutC l 98del,
pSLIV -mut7, pSLIV-mutGU, and pSLIV-mutCA.
Enzyme structure probing of RNA. . Enzyme structure probing was
carried out as previously described (Chapter II) except that primer extension
reactions on RNase-digested RNA were done with 5'-end-labeled plus-strand
binding oligonucleotide SR280(+) (Table 4.2; Fig. 4.1). Undigested RNA was
used with the same primer in dideoxynucleotidyl sequencing reactions to generate
a sequence marker.
Northern assay for DI RNA replication. The Northern assay was
performed as previously described (Chapters II and III).
Sequence analysis of the stem-loop IV region in progeny DI RNAs. For
direct sequencing of asymmetrically-amplified cDNA, the procedure as described
by Hofmann et al (Hofmann et al. , 1993) for analysis of plus-strand RNA was
used. Briefly, oligonucleotides TGEV8b(+) and SRleader(-) (Table 4.2) were
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Fig. 4. 1 . Phylogenetic and enzyme structure probing evi9ence for stem-loop IV
in BCoV genomic RNA. A. Predicted secondary structures within the 21 0-nt 5'
UTR of the BCoV genome and the site from which the 5' end-labeled primer was
extended for stem-loop IV structure determination. The 65-nt BCo V leader
sequence is shaded and the leader-associated UCUAAAC intergenic sequence
(nts 64-70, identified in bold) is found within loop II. The start and stop codons
for the stem-loop III associated intra-5' UTR ORF and the start codon for ORF la
are boxed. Previously described stem-loops I, II and III are identified. Stem-loop
IV is shown along with the variant bases found among the eight sequenced
members of group 2 coronaviruses (see text). Bases with no superscript are found
in all MHV strains (A59, 2, JHM); superscript identity: e, equine coronavirus; h,
HCoV-OC43. Stem-loop IV is identical in BCoV, HEV, and HECoV. B.
Enzyme probing data for stem-loop IV. Depicted is a DNA sequencing gel
showing separation of primer extension products. RNase digestion conditions for
the double strand-digesting CVl and single strand-digesting RNase T2 are
described in the text. Lanes 2 to 5 show the products of an RNA sequencing
reaction done on undigested RNA to identify the base positions. C. Summary of
enzyme probing data shown in part B.
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used for RT-PCR with RNA extracted at 48 hpi from cells infected with the first
passage virus (VP 1 ), and in some cases second passage virus (VP2), and 5 'end
radiolabeled oligonucleotide Hpal (-), SRDM(+), SR25 1 (+), or SR280(+) was
used for sequencing.
Protein binding assays. Preparation of cell lysates and the electrophoretic
mobility shift assays (EMSAs) essentially followed the procedures of Gamarnik
and Andino (Andino et al. , 1 990; Gamarnik et al. , 1 997). The method of probe
elution from preparative gels was that of Thomson et al (Thomson et al. , 1 999).
Cell lysates in 10 ul aliquots containing 20 ug total protein each were prepared at
6 h postinfection, or post-mock infection, as previously described (Chapter III).
For synthesis of the radiolabeled RNA probes for EMSAs and protein
crosslinking analyses, wt stem-loop IV-containing pSLIV(PB) and the (PB)
modifications of the stem-loop IV mutants (Table 4. 1) were linearized with
restriction endonuclease Nco I and transcribed with T7 RNA polymerase in a 50
ul reaction volume containing 1 20 uCi a32P-UTP (300 Ci/mmol). Transcripts
were 1 1 3 nts in length from all constructs except pSLIV-mutdel(PB) which were
93 nts. Radiolabeled transcripts were purified by electrophoresis on an 8 M
urea/6% polyacrylamide gel (Andino et al. , 1 990; Thomson et al. , 1 999) and
unlabeled transcripts used as competitor RNA were purified by chromatography
through a Biospin 6 column (BioRad).
EMSAs were carried out as described elsewhere (Chapter III). For the
supershift assays, 2 ul of antiserum (containing approximately 40 ug of protein
total) was added to the reaction mixture in one set before and in another set after
the RNA-protein binding reaction was complete and the mixture was incubated on
ice for 30 minutes prior to electrophoretic separation (Andino et al. , 1 990;
Gutierrez-Escolano et al. , 2000). Rabbit polyclonal anti PCBP-2 and preimmune
sera (Blyn et al. , 1 997) were kind gifts from E. Ehrenfeld (U. C. Irvine) and
mouse polyclonal anti-La antiserum was obtained from BD Biosciences.
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UV cross-linking and molecular weight determinations of RNA binding
proteins by SDS PAGE on gels of 1 0% polyacrylamide were carried out as
previously described (Chapter Ill).
Synthetic oligonucleotides and accession numbers. Oligonucleotides used
in this study are described in Table 4.2. GenBank accession numbers for the
sequences studied are U00735 for BCo V-Mebus, AF523843 for HCoV-OC43,
AF523844 for HECoV-4408, AF523845 for HEV-TNl 1 , AF523846 for ECoV
NC99, AF201 929 for MHV-2, NC00 1 846 for MHV-A59, M55148 for MHV
JHM, 234093 for TGEV-Purdue 1 1 6, 6972 1 for HCoV-229E, NC 00 145 1 for
IBV-Beaudette, and AY27874 1 for HCoV-SARS.

RESULTS
A predicted stem-loop IV in the BCoV 5' UTR shows phylogenetic
conservation among group 2 coronaviruses. Analysis of the 2 1 0 nt 5' UTR and
flanking sequences of the BCoV genome for RNA secondary structures using the

mfold program of Zuker (<http://bioinfo.math.rpi.edu/~zukerm/>, Mathews et al. ,
1 999; Zuker et al. , 1 999) pr�dicted the existence of a potential stem-loop with a
stem of ten base pairs containing an internal loop of 2 nts, a terminal loop of 8 nts,
and a free energy value of -9.8 kcal/mole (Fig. 4. 1 A). In the negative strand, a
bulged stem-loop with a terminal tetraloop and a free energy of -6.7 kcal/mole
was also predicted (Fig. 4.2).
The 5' UTR sequences for 1 2 coronaviruses species including the SARS
corona virus have now been reported enabling comparisons of predicted higher
order structures (see references described in GenBank accession numbers given
above). For. the eight members in group 2, BCoV-Mebus, HCoV-OC43, HECoV4408, HEV-67N, ECoV-NC99, MHV-2, MHV-A59, and MHV-JHM, the mfold
program predicted a stem-loop IV with small variations (stem-loop IV is identical
in BCoV, HECoV and HEV, and in MHV-2, MHV-A59 and MHV-JHM)
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kcal/mole are shown. Deleted bases in pSLIV-mutDel are
represented by A. Accumulation was measured by Northern
analysis with a reporter-specific radiolabeled oligonucleotide. For
Northern analyses, T7 RNA polymerase-generated transcripts of
linearized plasmids were transfected into BCoV-infected cells and
RNA was extracted at the indicated times post transfection and at
48 h postinfection with virus passage 1 (VP 1 ). Accumulation of
pDrep 1 progeny was considered to be 1 00%. The sequence of the
RNA in VPl progeny replicons was determined by bulk RT-PCR
sequencing using pDrep I -specific primers as described in the text.
Lanes: Uninf., mock infected, non-transfected cells; Inf., infected,
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(Fig.4. l Af A possible analog if not homolog is also found in coronavirus groups
1 and 3 and in the SARS coronavirus (see Discussion). The predicted stem-loop
IV for group 2 coronaviruses (i) has a stem of ten base pairs with either a two nt
internal loop as in BCoV, HCoV, HECoV, HEV and ECoV, or a four nt internal
loop as in MHV-2, MHV-A59 and MHV-JHM with net negative free energies
ranging from - 1 2 to -9.8 kcal/mole, (ii) has an 8-nt terminal loop whose sequence
is identical in BCoV, HECoV, HEV, MHV-2, MHV-A59 and MHV-JHM, and
differs by one base at nt position 1 97 in HCoV and ECoV, (iii) has a negative
strand counterpart with net negative free energies ranging from -8.9 to -6.7
kcal/mole, (iv) begins at base 1 83 for MHV-2 and MHV-A59, 1 85 for ECoV, 1 86
for BCoV, HCoV, HECoV and HEV, and 1 88 for MHV-JHM.
Thus, since a predicted stem-loop IV showed phylogenetic conservation in
all group 2 coronaviruses it was postulated to be a higher-order cis-acting element
in BCoV DI RNA replication.
Enzyme structure probing supports existence of stem-loop IV in BCoV
RNA. An in vitro-transcribed 595-nt transcript of Xba I-linearized pDrep 1 DNA
was digested with either single strand-specific RNases Tl (data not shown) or T2,
or with double strand-specific RNase CV l , and the products were analyzed by
reverse transcriptase extensions of the 5' end-labeled primer SR280(+) (Fig. 4. 1
B, lanes 1 1 -1 5 and 6-1 0). Radio labeled products of an RNA sequencing reaction
were analyzed in parallel to determine the sites of RNase digestion (Fig. 4. 1 B,
lanes 2-5). Enzyme probing indicated that the upper part of the stem (nts 1 90 to
1 95 and 204 to 209) is susceptible to digestion by only RNase CV l and is
therefore probably stably base-paired whereas the lower part of the stem (nts 1 86
to 1 89 and 2 1 2 to 2 1 5) appear susceptible to both RNases CV l and T2 and might
represent a breathing structure in which a base-paired state alternates with a single
stranded region. The predicted loop of stem-loop IV, on the other hand, is
strongly digested by RNase T2 and is therefore likely to be a single-stranded
region, consistent with it being a loop as predicted. The results of enzyme
90

structure probing overall show single- and double-strand regions in agreement
with an m/o/d-predicted structure for stem-loop IV (Fig. 4. 1 C).
Integrity of stem IV is required for BCoV DI RNA replication. The
rationale applied here for evaluating the functional importance of an RNA
element in DI RNA replication has been previously described (Chapters II and
III). Briefly, an element was deemed required if its removal or structural
disruption by mutation led to a loss of DI RNA accumulation at 24 h and 48 h
post transfection and an absence of mutated progeny molecules in VPl RNA. In
the case of a disrupted helical region, if restoration of the stem by compensatory
mutations leads to restored replication at 24 h and 48 h post transfection and the
presence of the double mutant progeny in VPl RNA then the stem is deemed a
required element. In an initial test to examine the requirement of stem-loop IV in
DI RNA replication, mutant pSLIV-mutDel was made and tested in which almost
the entire stem-loop was deleted (Table 4. 1 , Fig. 4.2). By Northern analysis, 7%
and 1 % of wt levels of DI RNA had accumulated by 24 and 48 hpt, respectively,
and less than 1 % had accumulated by 48 hpi in VP 1 . Sequence analysis of
asymmetrically amplified cDNA fr?m VPl DI RNA, however, showed all
progeny to be wild type and hence revertants, indicating the deletion mutant had
not replicated and thus stem-loop IV is probably necessary for replication.
To examine the importance of the helical nature of stem IV in DI RNA
replication, mutant pSLIV-mutL and pSLIV-mutR were made in which five of the
six base pairs in the upper helix were disrupted in the left and right arms,
respectively, leading to no predicted stem IV structure in either the positive or
negative strands (Table 4. 1 , Fig. 4.3). By Northern analysis, 1 0% or less of wt
levels of DI RNA had accumulated by 24 and 48 hpt and less than 1 % by 48 hpi
in VPl . Sequence analysis of asymmetrically amplified cDNA made from VPl
DI RNA showed the progeny of both mutants to be wt indicating they had not
replicated. By contrast, accumulation of progeny from the double mutant pSLIV mutL/R in which stem IV had been restored was 243% of wt levels at 24 hpt, 95%
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at 48 hpt, and 28% in VPl (Fig. 4.3). Asymmetrically amplified cDNAs from
VP l and VP2 DI RNA (not shown) showed progeny to have retained the double
set of mutations. These results, therefore, indicate that the helical region of stem
loop IV either in the positive or negative strand, or both, is required for DI RNA
replication. A lower rate of accumulation in the double mutant than in wt at VP 1
suggested factors other than the helical nature of the stem, possibly the nucleotide
sequence within the stem, might also be important for maximal accumulation.
Integrity of stem IV in the positive but not the negative strand is required
for BCoV DI RNA replication. Base pair covariations among group 2
coronaviruses maintain a stable stem-loop IV in both the positive (free energy
range, - 1 2 to -9.8 kcal/mole) and negative (free energy range, -8.9 to -6.7
kcal/mole) strands. The question of which strand stem-loop IV functions was not
answered by the stem IV disruption experiment described above since the helical
region had been disrupted simultaneously in both strands in the two non
replicating mutants, and wt net negative free energy values in both had been
restored in the replicating double mutant (Table 4. 1 ). Therefore, to test the strand
requirement for stem-loop IV, mutations in pDrep 1 were made such that either the
positive or negative strand was destabilized and transcripts were tested for
replication. For mutant pSLIV-mutGU, in which stem-loop IV was destabilized
in the negative but not positive strand (Table 4. 1 ), Northern analysis showed
220% of wt levels at 24 hpt, 1 32% at 48 hpt, and 1 1 4% in VPl , and sequence
analysis of asymmetrically-amplified cDNAs showed all progeny in VP 1 to be
mutant sequence thus indicating transcripts of pSLIV-mutGU had replicated (Fig.
4.4). By contrast, for mutant pSLIV-mutCA in which stem-loop IV had been
destabilized in the positive but not negative strand, Northern analysis showed an
accumulation of 1 9% of wt levels at 24 hpt, 1 5% at 48 hpt and 1 7% in VP 1 , and
sequence analysis showed all progeny from VP 1 to be wt molecules indicating the
mutant had not replicated .(Fig. 4.4). Taken together these results indicate that the

integrity of stem-loop IV for DI RNA replication is required in the positive but
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not the negative strand and that minor changes in stem sequence at least in the
mutated positions do not affect replication.
At least some aspects of wild type loop IV sequence are necessary for
BCoV DI RNA replication. The phylogenetic conservation of loop IV length and
partial primary sequence within group 2 coronaviruses (Fig. 4.1 A) led to the
hypothesis that loop IV plays a role in the function of stem-loop IV. In the first of
two mutants made to test this notion, C3 in the 8-nt loop was deleted creating
pSLIV-mutC 198del (Fig. 4.5 A). In the second, C4 and C5 in the loop were
changed to U's creating pSLIV-mut7 (Fig. 4.5 B). The free energies of stem-loop
IV in both constructs were identical to wt (Table 4.1). Although for construct
pSLIV-mutC 198del only mutant sequences were found in VPl progeny thus
showing replicability of the mutant molecules, accumulation was two-fold less at
24 and six-fold less at 48 hpi (VP 1) than wt indicating wt loop length or sequence
integrity may contribute to optimal DI RNA replication. Northern analysis of
progeny from pSLIV-mut7, on the other hand, showed accumulation rates of less
than 3 % of wt throughout, and sequence analyses showed only wt in VPl progeny
indicating mutant molecules had not replicated. Taken together these results
indicate that loop IV is an important component of the stem-loop IV cis-acting
element required for DI RNA replication.
Eight cellular proteins bind specifically to wild type stem-loop IV RNA
but not to mutated nonfunctional forms. To test the hypothesis that stem-loop IV
functions through interactions with cellular or viral proteins, plasmid pSLIV(PB)
encoding wt stem-loop IV was linearized at the Nco I site and used to generate
uniformly labeled 113-nt transcripts for electrophoretic mobility shift assays. On
incubation with lysates of BCoV-infected (Fig. 4.6, lane 3) or mock-infected (lane
4) cells, three distinct bands of lower mobility were apparent whereas no change
in mobility was observed when probe was incubated with buffer alone (lane 1), or
when proteinase K was added to infected cell lysate prior to the addition of probe
95
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Fig. 4.6. Cellular but not viral proteins bind specifically to stem
loop IV-containing RNA. A uniformly labeled 1 13 nt stem-loop
IV -containing RNA probe was used in electrophoretic mobility
shift assays as indicated. Probe treatments: Lane 1 , incubated
with buffer; lane 2, incubated with proteinase K-treated infected
cell lysate; lane 3, incubated with infected cell lysate; lane 4,
incubated with uninfected cell lysate; lanes 5-7, incubated with
uninfected cell lysate to which had been added 5, 1 0, and 1 5 ug
of unlabeled probe RNA, respectively; lanes 8-1 0, incubated
with uninfected cell lysate to which had been added 5, 1 0, and
1 5 ug yeast tRNA, respectively.
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(lane 2). These results indicate that all three complexes were formed at least in
part by interactions with cellular but not viral proteins. The complexes,
furthermore, were specific to stem-loop IV-containing RNA since addition of
increasing amounts of unlabeled probe as competitor reduced complex formation
in a dose dependent manner (Fig. 4.6, lanes 5 to 7) whereas addition of tRNA, a
presumed nonspecific competitor, did not (lanes 8 to 10). These results together
indicate that stem-loop IV-containing RNA is a binding target for cellular but not
viral proteins.
To determine whether the proteins are binding to the 30-nt stem-loop IV
element, and, simultaneously, to establish whether binding is specific to the wt
like helical structure, electrophoretic mobility shift assays were done in a way that
compared the four functional (including wt) and five nonfunctional mutated forms
of stem-loop IV (Table 4. 1 and Fig. 4.7). Interestingly, transcripts from all eight
mutant constructs were shifted to form the three RNA-protein complexes similar
to those found with wt stem-loop (Fig. 4.7). These results indicate that at least
some cellular proteins are binding to the transcripts regardless of the replicating
potential of the mutant.
To determine the number and sizes of the proteins in the complexes, UV
cross-linking between the radiolabeled RNA and proteins was done followed by
digestion with a mixture of single strand and double strand-specific RNases and
SDS PAGE analysis. By this analysis, eleven distinct bands representing
approximate molecular weights of 78, 64, 58, 48, 45, 4 1 , 39, 33, 28, 26, and 25
kDa were found when wt RNA was used with lysates of uninfected (Fig. 4. 8 A,
lane 5,. and Fig. 4.8 B, lane 8) or infected (Fig. 4.8 A, lanes 1 and 4, and Fig. 4.8
B, lane 9) cells. This was consistent with the finding that shifting patterns were
the same between infected and uninfected cells indicating that cellular but not
viral proteins were binding to the stem-loop IV-containing RNA. The elimination
of all eleven bands with proteinase K treatment (Fig. 4.8 A, lane 2, and Fig. 4.8 B,
lane 1) established their protein identity. Additionally, all eleven cellular proteins
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bound specifically to the stem-loop IV-containing RNA since addition of 1 500fold excess of unlabeled transcript prevented complex formation (Fig. 4.8 A, lane
3) whereas the same amount of yeast tRNA did not (Fig. 4.8 A, lane 4).
Interestingly, whereas all eleven cellular proteins bound probe from wt
(Fig. 4.8 A, lanes 1 , 4 and 5, and Fig. 4.8 B, lanes 8 and 9) and replicating mutant
constructs (mutL/R, Fig. 4.8 B, lane 3; mutGU, Fig. 4.8 A, lane 8; and
mutC l 98del, Fig. 4.8 B, lane 4), only three cellular proteins with molecular
weights of 48, 45 and 33 kDa bound probe from the non-replicating mutants
(mutDel, Fig. 4.8 A, lane 7; mutL, Fig. 4.8 B, lane 6; mut R, Fig. 4.8 B, lane 5;
and mut7, Fig. 4.8 B, lane 7). These data together indicate the eight proteins with
molecular weights of 78, 64, 58, 4 1 , 39, 28, 26 and 25 kDa were interacting with
stem-loop IV in a function-dependent manner and that the interaction might
reflect a mechanistic feature of stem- loop IV function in BCo V DI RNA
replication.

DISCUSSION
In this study, we have shown by enzyme structure probing the existence of
a predicted bulged stem-loop IV mapping at nts 1 86 through 2 1 5 and therefore
lying mostly within the 2 1 0-nt 5 ' UTR of BCoV DI RNA. Stem-loop IV shows
phylogenetic conservation in structure and largely also in sequence among the
group 2 coronaviruses, and although it is predicted to exist in the minus strand as
well, it was shown by mutation analysis in DI RNA to function in replication only
in the positive strand. At least part of the primary sequence of loop IV was found
to be essential for DI RNA replication. Protein binding studies, furthermore,
demonstrated that eight cellular and no viral proteins bind specifically to wt and
functional mutated forms of stem-loop IV but not to mutated nonfunctional forms.
It is not currently known whether the eight cellular protein species
represent wholly intact molecules or disassembled polypeptides of larger proteins,
nor is the identity of any of the proteins known. The fact that the conserved loop
1 03

IV sequence of 5'CACCCAUA3' in group 2 coronaviruses contains the ACCCA
motif also found in 5' ACCCACCC3', a poly(C)-protein binding sequence in the
poliovirus genome (Gamarnik et al. , 1998; Parsley et al. , 1997), led us to test
whether the 39 kDa poly(C)-binding protein was one of the proteins binding stem
loop IV. An electrophoretic mobility supershift assay with antiserum to poly(C)
binding protein, however, showed no supershifted complex indicating this protein
is probably not one of the binding proteins (data not shown). Nor was
supershifting observed when antiserum to the 47 kDa La cellular protein, a
protein known to react with a variety of cellular and viral RNAs (Yocupicio
Monroy et al. , 2003; and references therein), was tested. To our knowledge, in no
study has a protein been identified that binds to the region of the coronavirus
genome encompassing stem-loop IV.
ls there a stem-loop IV equivalent in coronavirus groups 1 and 3, and in
the SARS coronavirus? Since the coronavirus genomic 5' UTRs range in length
from 210 nts in BCoV to 528 in IBV, it is not immediately apparent what
predicted folded structures might be analogous among them. By the arbitrary
criteria of (i) the most probable higher-order structure predicted by the Zuker
algorithm (i.e., the structures having the highest pnum value), (ii) distance from
the genome 5' terminus (and hence also from stem-loop III, a predicted homolog
found similarly positioned from the 5' end in groups 1, 2 and 3 [Chapter 11;
Raman et al. , 2003 ]), and (iii) apparent conserved features such as loop sequence,
we postulate likely analogs of stem-loop IV in group 1 and the SARS coronavirus,
but a less likely analog in group 3 (Fig. 4.9). In IBV, however, a stable stem-loop
structure with high pnum values and a structure loosely resembling the first (i.e.,
most upstream) of duplicate stem-loop structures in group I and SARS
coronavirus, but starting at nt 325, is found (Fig. 4.9). Thus, perhaps our second
arbitrary criterion is not applicable with such a long 5' UTR as found in IBV. In
the group I coronaviruses TGEV and PEDV, and in the SARS coronavirus, the
loop of stem-loop IV is a highly conserved hexaloop (UU[U/C]CGU), and stem
loop IV appears duplicated in TGEV and in the SARS coronavirus, and three
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Fig. 4.9. Potential stem-loop IV equivalent structures in coronavirus
groups 1 and 3, and the SARS coronavirus, as predicted by the Zuker
mfold algorithm.

1 05

times in PEDV with the same hexaloop sequence (Fig. 4.9). We have used the
terms stem-loops IV-1, IV-2, and IV-3 to identify these (Fig. 4.9). In the group I
coronavirus HCoV-229E, stem-loop IV appears two times with a nearly identical
hexaloop sequence in one and pentaloop sequence in the other (UUCCG[U]) (Fig.
4.9). In the group III coronavirus IBV, a stem-loop IV-like structure is predicted
beginning at nt 325 (Fig. 4.9). The free energies of these structures, both in the
positive and negative strands, are given in Fig. 4.9 and its legend.
How does stem-loop IV in BCoV DI RNA function mechanistically in
replication? Previous studies using BCoV DI RNA had indicated that ORF la is
translated by ribosomal scanning from the 5' end of the genome (Senanayake et
al., 1999) and thus it is unlikely that stem-loop IV is a required structure for

directing an "intemal entry of ribosomes for the translation of ORF la. It is
therefore proposed that stem-loop IV along with stem-loop III functions in the
formation of the RNA replication complex. This concept is consistent with the
observation that stem-loop IV is part of a contiguous 421-nt sequence found in the
BCoV DI RNA but missing in subgenomic mRNA 7 that, despite being identical
to the DI RNA replicon in every other respect, fails to replicate after transfection
into helper virus-infected cells (Chang et al., 1994). Since the higher-order
integrity of stem IV in only the positive RNA strand is required for replication
(Table 4.1, Fig. 4.4)), one possibility is that it functions as a cis-acting element in
the initiation of negative strand synthesis. This notion has precedence in the
behavior of other plus-strand RNA viruses where physical interactions between
the genome 5' and 3' ends are necessary for initiation of negative-strand RNA
synthesis. In some cases as in flaviviruses the cyclization results from RNA-RNA
interactions (Corver et al., 2003; Khromykh et al., 2001; You et al., 1999; You et
al., 2001). In other cases as in poliovirus and alphaviruses, the interaction is

through protein bridges (Barton et al., 2001; Herold et al., 2001; Frolov et al.,
2001). In BCoV DI RNA the interaction of stem-loops III and IV with proteins
would suggest bridging and circularization, if it occurs, would be through proteins
(Chapter III, Fig. 3.10).
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A positive correlation between the binding of eight cellular proteins to
stem-loop IV and replication ability of the DI RNA suggests that stem-loop IV
functions in replication through its interaction with these proteins. Further
analyses to identify these proteins and determine how they interact with each
other and with stem-loop IV should provide insight into how stem-loop IV
functions in DI RNA replication.
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CHAPTER V. FUTURE DIRECTIONS.
INTRODUCTION
With the recent interest in coronavirus research after the severe acute
respiratory syndrome outbreak, it has become essential to better understand the
mechanism of replication of these viruses, with a view to develop drugs and
vaccines to combat this illness.
In this dissertation, two phylogenetically conserved, cis-acting RNA
secondary structural elements, stem-loops III (Chapter II) and IV (Chapter IV)
have been identified that are required for BCoV DI RNA replication. In addition
to this, a replication enhancer element, the stem-loop III associated 5' UTR ORF
has been identified (Chapter II). These elements are proposed to be required for
viral genome replication in addition to DI RNA replication, and are postulated to
function in the formation of the viral replication complex that is made up of
cellular and viral proteins that interact with these structures. This study opens up
interesting future directions of research in the following aspects of coronavirus
replication:

TO IDENTIFY AND CHARACTERIZE THE PROTEINS THAT
INTERACT WITH STEM-LOOPS III AND IV
In this dissertation, stem-loop III has been proposed to function through its
interactions with cellular and viral proteins (Chapter III), and stem-loop IV has
been proposed to function through its interactions with cellular proteins (Chapter
IV). The proteins interacting with these two structures could be identified by first
purifying them using RNA affinity purification using synthetic, biotinylated RNA
containing stem-loop III or IV bound to streptavidin beads, and the proteins could
be identified by mass spectrometry and peptide microsequencing. The identities
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of these proteins could then be confirmed by using electrophoretic mobility
supershift assays using antibodies that are specific to these proteins. The precise
binding site of these proteins on stem-loops III and IV (the exact nucleotides that
interact with these proteins) could be mapped out using RNA footprinting assays.
Further, the interactions of the different proteins with each other, within the
protein complex that binds to stem-loops III and IV could be studied using co
immunoprecipitation assays and yeast two hybrid assays.
Towards understanding the role that each of the stem-loop binding
proteins play, expression of each of the identified proteins could be silenced using
siRNA (short interfering RNA), and virus replication in the absence of that
protein could be studied and compared to virus growth in a system that is
reconstituted with that protein.

TO DETERMINE THE X-RAY STRUCTURE OF RNA-PROTEIN
COMPLEXES OF STEM-LOOPS III AND IV
The X-ray structure of the RNA-protein complex of the Rotavirus
nonstructural protein NSP3 bound to a rotaviral mRNA 3 ' end has been
determined (Deo et al. , 2002). Using the protocol in that study, the RNA
containing stem-loop III or IV could be co-crystallized with the purified proteins
that bind these RNA structures, and the RNA-protein X-ray structure could be
determined. This study would provide valuable insights into the specificity of
protein-RNA binding in the formation of the viral replication complex.

TO DETERMINE THE SECONDARY STRUCTURE OF THE
BCoV 5 ' UTR NEGATIVE-STRAND RNA
Though both stem-loops III and IV can potentially exist in both the
positive as well as in the negative RNA strands, only stem-loop III has been
1 09

proposed to function in replication in both the positive and negative strands
(Chapter III). Stem-loop IV has been proposed to function in only the positive
RNA (Chapter IV). The higher-order structures of both stem-loops III and IV
have been mapped out in the positive-strand using enzyme probing assays, in this
dissertation (Chapters II and IV). Secondary RNA structures that could
potentially function in replication, in the 5' UTR negative-strand could be mapped
out using the enzyme probing protocol described in this dissertation. Then, these
structures could be selectively destroyed in the negative-strand RNA, and the
effect of these mutations on replication could be examined.

TO CHARACTERIZE THE ROLE OF STEM-LOOPS III AND IV
IN NEGATIVE-STRAND RNA SYNTHESIS
RNase protection assays described in the appendix of this dissertation
(Fig. A.2) hint at the possibility that stem-loops III and IV might function in
negative-strand RNA synthesis. Non-replicating stem-loop III and IV mutants
were shown by this assay to synthesize lower levels of negative-strand RN A than
the wild type BCoV DI RNA. Further examination of the possibility that stem
loops III and IV function in negative-strand RNA synthesis could be done. For
this, the sequences of the negative RNA strands synthesized by the stem-loop III
and IV mutants could be determined to ascertain whether these mutants maintain
their mutant sequences during negative-strand synthesis.. Also, RNase protection
assays for negative-strand RNA synthesis at different time points could be done.
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A PREDICTED STEM-LOOP III ANALOG WITH AN ASSOCIATED
SHORT ORF EXISTS IN PEDV AND IN HCoV-SARS
Chapter II of this dissertation describes a cis-acting replication element,
stem-loop III that maps at nts 97 through 1 1 6 in the BCoV 5' UTR. Stem-loop III
in BCoV has associated with it beginning at nt 100 an AUG-initiated intra-5'
UTR open reading frame that is proposed to function as an enhancer of
replication. Stem-loop III and its associated ORF show phylogenetic
conservation among all sequenced group 2 coronaviruses, group 1 coronaviruses
TGEV and HCoV-229E, and group 3 coronavirus IBV. Though stem-loop III has
an ORF associated with it in all coronaviruses, the length and sequence of the
oligopeptides encoded by this ORF are dissimilar.
Mfold analysis of the 5' UTR sequences of the recently sequenced group 1

coronavirus PEDV, and the HCoV-SARS coronavirus, indicated that a bulged
stem-loop III analog with associated intra-5' UTR ORFs is positioned similarly
within the 5' UTR (Fig. A. 1 ). The predicted loop III is a tetraloop in PEDV
(loop III is a tetraloop in BCoV), and is a pentaloop in HCoV-SARS. PEDV has
two stem-loop III associated intra-5' UTR ORFs, like in HCoV-229E. In PEDV
these two ORFs code for peptides with sequences MFMLLEAGVEFH, and
MLLEAGVEFH. The stem-loop III associated intra-5' UTR ORF in HCoV
SARS encodes a ten amino acid long peptide with the sequence MPSAPTQYKQ.
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Fig. A.1 . Potential stem-loop III analogs in PEDV and in HCoV-SARS
predicted by the Zuk.er mfold alogrithm. AUG codons for potential
stem-loop III associated ORFs are boxed.
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NON REPLICATING MUTANTS OF STEM-LOOPS III AND IV SHOW
DECREASED LEVELS OF NEGATIVE-STRAND RNA SYNTHESIS
Stem-loop III has been proposed to function as a cis-acting element in the
synthesis of both negative and positive-strand RNA (Chapter III of this
dissertation), and stem-loop IV has been proposed to function as a cis-acting
element in the synthesis of negative-strand RNA (Chapter IV of this dissertation).
Therefore, to test the hypothesis that both stem-loops III and IV function as cis
acting elements in negative-strand RNA synthesis, all the stem-loop III and IV
mutants tested for replication (or positive-strand synthesis by Northern assays)
were tested for negative-strand RNA synthesis by RNase protection assays.
Briefly, a uniformly labeled 237 nt RNA probe containing nts 1 0 1 1 to
1 1 97 of BCoV DI RNA positive-strand was generated as described in the RNase
protection assay protocol. Therefore, the probe used had 1 86 nts that were
specific to BCoV DI RNA and 51 nts of vector sequence. Besides this, part of the
sequence that the probe was specific to was the 30-nt reporter sequence in the DI
RNA that was not present in the wild type helper virus. The 30-nt sequence made
it possible to distinguish between DI RNA and helper virus negative strands. This
probe was used in a two-cycle RNase protection assay to assay for DI RNA
negative-strand synthesis at 6 hours post transfection (Fig. A.2). A band
migrating at the 1 86-nt position (corresponding to the region of the probe that was
protected from RNase digestion) was apparent with RNA from cells transfected
with wild type DI RNA (lane 1 6), but not with RNA from infected, mock
infected, or transfected but not infected cells (lanes 1 9, 1 8, and 1 7, respectively).
Stem-loop III non-replicating mutants (Chapter III, Table 3. 1 ) pSLIII-mut2L (lane
1 5), pSLIII-mut2R (lane 1 4), pSLIII-mutGU (lane 4), and pSLIII-mutCA (lane 5)
showed lower levels of negative strand synthesis (lower levels of the 1 86-nt band)
than wild type DI RNA (lane 16) or stem-loop III replicating mutant pSLIII
mut2L/R (lane 1 3). Interestingly, the stem-loop III associated ORF mutant
pSLIII-mut4L/R that did not replicate (lane 1 2) and the stem-loop III associated
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Fig. A.2. Nonreplicating mutants of stem-loops III and IV show
decreased levels of negative-strand RNA synthesis by the RNase
protection assay. Lanes 1 and 20, molecular weight markers; lane 2,
pSLIV-mutCA; lane 3, pSLIV-mutGU; lane 4, pSLIIl-mutGU; lane 5,
pSLIII-mutCA; lane 6, pSLIV-mut7; lane 7, pSLIV-mutDel; lane 8,
pSLIV-mutL/R; lane 9, pSLIV-mutR; lane 1 0, pSLIV-mutL; lane 11 ,
pSLIII-mut3L; lane 12, pSLIII-mut4L/R; lane 13, pSLIII-mut2L/R;
lane 14, pSLIII-mut2R; lane 15, pSLIII-mut2L; lane 16, wild type DI
RNA; lane 17, RNA from transfected but not infected cells; lane 18,
mock-infected cells; lane 19, infected cells; lane 21, 5 X 105 cpm of
undigested probe.

128

ORF mutant pSLIII- mut3L that did replicate (lane 1 1 ) showed near wild type
levels of negative-strand synthesis. The stem-loop IV non-replicating mutants
(Chapter IV, Table 4.1 ) pSLIV-mutL (lane 1 0), pSLIV-mutR (lane 9), pSLIV
mutDel (lane 7), pSLIV-mut7 (lane 6), and pSLIV-mutCA (lane 2) showed lower
levels of negative-strand synthesis than wild type DI RNA (lane 1 6) or stem-loop
IV replicating mutants pSLIV-mutL/R (lane 8), and pSLIV-mutGU (lane 3).
Though these results hint at the possibility that stem-loops III and IV
might function in negative-strand RNA synthesis, it is not known at this time
whether the negative strands that were detected in the mutants had maintained
their mutant sequences or if they had reverted to wild type sequence. Further
examination of mutant negative-strand sequences, as well as assays for negative
strand synthesis at different time points post transfection need to be done to better
understand the role of stem-loops III and IV in negative-strand synthesis.
RNASE PROTECTION ASSAY PROTOCOL
To generate the minus-strand RNA probe, plasmid derivative pDrepRPA
was constructed by overlap PCR mutagenesis in which primers pDrep 1 ( 1 1 88)(+)
(which binds to nts 1 1 80 through 1208 of pDrepl DNA and had sequence:
GGAGAGGATCCGGTTCTGTTGCCAGAATT) and pDrepl(l 1 1 1 )(-) (which
binds to nts 984 through 1 028 and had sequence:
CGATCGGTACCTATTCCGACTAGGTTTCC), and pDrep 1 DNA were used to
make a 208 nt product that had a BamHl restriction endonuclease site at nt 1 1 97
and a Kpnl site at nt 1 0 1 1. The 208-nt PCR product was trimmed to 1 86 nts with
enzymes BamHl and KpnI, and cloned into BamHl /KpnI-linearized pGEM3Z
vector. pDrepRPA DNA was linearized with Hind III restriction endonuclease
and transcribed with T7 RNA polymerase in a 50 ul reaction volume in the
presence of a32P-UTP (300 Ci/mmol). Transcripts were 23 7 nts in length and
were purified by electrophoresis on an 8 M urea/6% polyacrylamide gel.
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The two cycle RNase protection assays followed the procedures of Novak
and Kirkegaard (Novak et al. , 1 99 1 ). Briefly, cells at 80% confluency in 35mm
diameter dishes were infected with BCoV at a multiplicity of 1 0 PFU per cell and
transfected with 500 ng of DI RNA transcript in Lipofectin at 1 hpi. For the first
cycle of the RNase protection assay, RNA extracted from one 35mm dish by the
NP-40-proteinase K method (yielding approximately 1 0 ug per dish) was
resuspended in 30 ul of hybridization buffer (40 mM PIPES, 400 niM NaCl, 1
mM EDTA, 80% formamide), denatured at 85°C for 5 minutes and then
hybridized overnight at 45°C. RNase digestion was then carried out by adding
300 ul of RNase mix buffer ( 1 0 mM Tris-Cl pH 7.5, 1 M NaCl, 5 mM EDTA, 1 05
U RNase Tl, and 2.6 U RNase A (Ambion) and incubation at 25°C for 1 hour.
The samples were then subjected to phenol chloroform treatment and ethanol
precipitation. In the second cycle, the RNA from the first cycle was resuspended
in 30 ul of hybridization buffer and 5 x 1 0 5 cpm of the 32P-UTP labeled probe was
added to this. After denaturation of the samples at 85°C for 5 minutes,
hybridization of the probe to the negative strand RNA was carried out overnight
at 45° C. RNase digestion of the samples was then carried out by adding 300 ul of
RNase mix buffer and incubation at 25°C for 1 hour. After phenol chloroform
extraction, the RNA was separated on a DNA sequencing gel of 6%
polyacrylamide.
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DETAILED PROTOCOL FOR ELECTROPHORETIC MOBILITY SHIFT
ASSAY
PREPARATION OF CELL LYSATES
Freshly confluent HRT cells in 35 mm diameter dishes were either mock
infected or infected with 200 ul of BCoV. At 6 hpi, cells were washed once with
ice cold phosphate buffered saline and then harvested by scraping with the broad
end of a blue tip and transferred to an Eppendorf tube. Cells were then
centrifuged for 4 minutes at 600 X g and 4°c. The supernatant was discarded and
the cell pellet was then resuspended by vortexing in approximately 4 packed cell
volumes of lysis buffer (5 mM HEPES [pH 7.9], 25 mM KCl, 2 mM MgCh, 4%
glycerol, 20 mM DTT, 0.1 mM PMSF, 0.2 mM EDTA, 1 % [v/v] NP-40), kept on
ice for 20 minutes, then transferred to a douncer, and homogenized by douncing
with 30 strokes in a tight-fitting Dounce homogenizer. The lysate was transferred
to an Eppendorf tube and nuclei were removed from the lysate by centrifugation
at 700 X g for 1 0 minutes at 4°C. The supernatant was transferred to a fresh
Eppendorf tube (this is the lysate that will be used for EMSA), and the pellet
containing the nuclei was discarded. Total protein in the lysate was quantitated
with the Bradford kit from BioRad according to the instructions in the kit. The
lysate was then diluted if necessary with lysis buffer and divided into 10 ul
aliquots containing 20 ug total protein each and stored at -80° C until use.
SYNTHESIS OF RADIOLABELED RNA PROBE AND COLD
COMPETITOR RNA
For synthesis of the radiolabeled RNA probes and cold competitor RNA,
wild type stem-loop IV-containing plasmid construct pSLIV(PB) was linearized
with Nco I and stem-loop III containing plasmid construct pSLIII(PB) was
linearized with Avril. Transcription of cold competitor RNA, using T7 RNA
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polymerase was carried out and the transcripts were chromatographed through
Biospin 6 columns and stored at -20°C until use.
Transcription of radiolabeled RNA probe was carried out in a 50 ul
volume by mixing together 1 0 ul of 5 X Transcription buffer, 5 ul of 1 00 mM
DTT, 2.5 ul of acetylated BSA (2 mg/ml), 1.25 ul of RNasin (40 U/ul), 1 0 ul of
rNTP mix (2.5 mM each of rATP, rGTP, rCTP), 2.5 ug of linearized DNA, 1 ul of
T7 RNA polymerase (40 U), 6 ul of 1 00 uM UTP, and 1 2 ul of a32P-UTP (300
Ci/mmol). Transcription was carried out for one hour at 37°C. After one hour 2.5
U of RQ RNase free DNase (1 U/ul) was added to the transcription reaction, and
the reaction was incubated for 30 minutes at 37°C. The reaction was phenol
chloroform extracted once, and 50 ul of sequencing stop dye was added and the
components were electrophoretically separated on an 8 M urea, 6% PAGE gel.
The gel was exposed to X ray film for 1 0 minutes to determine the position of the
probe on the gel and the region of the gel containing the probe was cut out and
placed into a 1 5 ml conical tipped tube. The probe was eluted in elution buffer
(0.5 M ammonium acetate, 1 mM EDTA) overnight with constant rotation at 4°C.
The probe was then ethanol precipitated and resuspended in 20 ul of water and the
radioactive content of the probe was measured by Cerenkov counting. The probe
was then diluted to 2 X 1 04 cpm/ul, cerenkov counts.
RNA-PROTEIN BINDING REACTION
For the EMSA, the 32 P-UTP labeled probe and unlabeled competitor
RNAs were renatured separately. For this, approximately 10 ul of RNA (2 X 1 04
cpm/ul of probe) was added to 1 0 ul of 2 X renaturation buffer ( 40 mM HEP ES
[pH 7.9], 1 20 mM KCl, 4 mM MgCh), and the mixture was incubated for 30
minutes at 45° C. In the meantime, the cell lysates in 1 0 ul aliquots were thawed
on ice, and 1 0 ug yeast tRNA in 1 ul, lul of 1 00 mM PMSF, and 1 ug heparin in 1
ul were added to the lysate. Cold competitor RNA was added in certain
experiments. This mixture was preincubated without the RNA probe for 1 0
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minutes at 30° C, then 1 ul of the renatured probe (1 X 104 cpm of 32P-UTP
labeled probe) was added to the mixture and the mixture was incubated at 30° C
for 10 min. 2 ul of 50% glycerol was then added, and the products were
electrophoretically separated on a 6% native polyacrylamide/5% glycerol gel at 4°
C using 0.5 X TBE ( 1 X is 0.09 M Tris, 0.09 M boric acid, 0.002M EDTA) as
electrophoresis buffer.
For UV cross-linking and molecular weight determinations the RNA
protein binding reaction mixtures, before the addition of glycerol, were irradiated
at 3 mwatts/cm2 on ice for 30 minutes in a Stratalinker UV cross linker 1 800 and
the preparation was digested with 1 00 U of RNase Tl, 2.5 U of RNase A and 1 U
of RNase CV 1 (Ambion) for 40 minutes at 3 7° C. After digestion, equal volumes
of SDS-PAGE loading dye was added to the samples and the products were
electrophoretically separated on an SDS PAGE gel of 10% polyacrylamide. Gels
were dried and analyzed with a Packard Instantlmager Autoradiography System
and exposed to Kodak XAR-5 film for 1 to 10 days at -80°C for imaging. Images
were recorded by digital scanning of the film.
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